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1. INTRODUCTION 
Analysis plays a major role today, and it can be considered as an 
interdisciplinary subject. Pharmaceutical Analysis derives its principles from various 
branches like chemistry, physics, microbiology etc., pharmaceutical analytical 
techniques are applied mainly in two areas, viz quantitative analysis and qualitative 
analysis, although there are several other applications. 
Today, more than 80% of all analytical chromatographic separations are 
performed using reversed-phase adsorbents which have shown higher versatility 
compared to normal-phase chromatography adsorbents. Reversed-phase adsorbents 
have found their use in a wide range of applications such as process purification, 
isolation of active bio molecules, analytical separation of drugs and metabolites as 
well as extraction of various contaminants in environmental samples. 
However, Reversed-Phase Chromatography includes a large number of 
different phases that differ significantly in both chemical and physical properties 
which will have a significant impact on their chromatographic behaviours. Thus, one 
chromatographer will have to consider all of the following stationary phase properties 
while gathering information on the sample to be analyzed or purified such as 
1. Hydrophobicity 
2. Particle and Pore Diameter 
3. Bonding Chemistry (Surface Coverage, Polymeric vs Monomeric) 
4. Particle Geometry (Irregular vs Spherical) 
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5. Silica Purity 
6. Analyte pKa 
7. Molecular Weight 
8. Sample   Matrix   (pH,   salts,   concentration,   interference)Analytical 
techniques 
Drugs and pharmaceuticals are chemicals or like substances, which are of 
organic, inorganic or other origin. Whatever may be the origin, we use some property 
of the medicinal agent to measure them qualitatively or quantitatively. Pharmaceutical 
analytical techniques, which are being used, can be categorized as follows.  
Spectroscopy: 
The light absorption (or) emission characteristics of drugs are measured in 
UV-Visible, IR, NMR, ESR, fluorescence and mass spectroscopy. 
Chromatography: 
It is a separation technique where the affinity or partition co-efficient 
differences between the drugs are recorded with TLC, HPLC, GC, Column and paper 
chromatography. 
Electro analytical techniques: 
It is measured based on the electrochemical property of drugs and classified as 
potentiometry, conductometry, polarography, amperometry and paper electrophoresis. 
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Radioactive methods: 
In this method, radiation intensity from a radioactive substance or an induced 
radioactive substance arising from exposure of the sample to a neutron source is 
measured using scintillation counters, e.g., Radio Immuno Assay. (Beckett A.H, 
1997) 
Physical methods: 
The physical characteristics of drugs are measured such as DSC, DTA, TGA 
and TMA. 
Titrimetric methods: 
It is based on the reaction between titrant and titrate and the end point detected 
by the addition of a suitable indicator reagent. It is classified in to several types based 
on the reaction which is non aqueous, redox, diazotization and complexometric 
titrations. 
X-ray methods: 
In this, x-ray is used to identify certain emission peaks, which are 
characteristics of elements contained in the target. The wavelength of the peak can be 
related to the atomic numbers of the elements producing them. 
Hyphenated techniques: 
It is the combination of two or more methods where separation and 
identification is possible by using coupled instruments such as GC-MS and LC-MS. 
(ICH Topic Q2A. Text Nov’1996) 
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Classification of chromatography techniques: 
A. Based on modes of chromatography: 
 Normal phase chromatography  
 Reverse phase chromatography 
B. Based on principle of separation:  
 Adsorption chromatography 
 Ion exchange chromatography  
 Size exclusion chromatography 
 Affinity chromatography 
 Chiral phase chromatography 
C. Based on elution: 
 Isocratic separation  
 Gradient separation 
D. Based on the scale of operation: 
 Analytical HPLC 
 Preparative HPLC 
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Normal Phase: 
The hydrophilic molecules in the mobile phase will tend to adsorb to the 
surface on the inside and outside of a particle if that surface is also hydrophilic. 
Increasing the polarity of the mobile phase will subsequently decrease the adsorption 
and ultimately cause the sample molecules to exit the column. This mechanism is 
called Normal Phase Chromatography. It is a very powerful technique that often 
requires non-polar solvents. Due to safety and environmental concerns this mode is 
used mostly as an analytical technique and not for process applications. (Chatwal.R., 
et.al., 2000) 
Reverse Phase: 
The reverse phase chromatography, results from the adsorption of 
hydrophobic molecules on to a hydrophobic solid support in a polar mobile phase. 
Decreasing the mobile phase polarity by adding more organic solvent reduces the 
hydrophobic interaction between the solute and the solid support resulting in de-
sorption. The more hydrophobic the molecule the more time it will spend on the solid 
support and the higher the concentration of organic solvent that is required to promote 
de-sorption. (Sharma B.K 1999). 
Reversed phase chromatography (RPC) is the most popular separation 
technique at analytical scale, because: 
 RPC applies to a very wide range of molecules including charged and polar 
molecules, 
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 RPC allows precise control of variables such as organic solvent type and 
concentration, pH, and temperature, 
 RPC columns are efficient and stable,  
 RPC is a robust technique. 
High Performance Liquid Chromatography: 
The analytical technique of High Performance of Liquid Chromatography 
(HPLC) is used extensively throughout the pharmaceutical industry. It is used to 
provide the information on the composition of drug related samples. The information 
obtained may be quantitative, indicating what compounds are present in sample or 
quantitative, providing the actual amounts of compounds in the sample. HPLC is used 
at all the different stages in creation of new drug and also is used routinely during 
drug manufacture. The aim of analysis will depend on the both the nature of the 
sample and the stage of the development. HPLC is a chromatographic technique; 
therefore it is necessary to have basic understanding of chromatography to understand 
how it works. (Donald Willings A 2011). 
Chromatography: 
A Russian botanist, Mi Khail Tswett is credited with the first use of 
chromatography in 1906 when he separated plant pigments such as chlorophylls and 
xanthophylls. He passed them through a glass column packed with calcium carbonate. 
These pigments are coloured and thus the technique was named using the Greek 
terms, 'chroma' meaning 'colour', and 'graphein' meaning ' to write1. This explains 
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why the name seemingly bears little relation to the use of technique today. (Beckett 
2002, Galen W.E 1977). 
Chromatography is a technique which separates components in a mixture due 
to the different time taken for each component to travel through a stationary phase 
when carried through it by a mobile phase. 
The possible mixtures of phases give rise to the types of chromatography listed in 
below table. 
Types of Chromatography: 
TYPE OF CHROMATOGRAPHYMOBILE PHASE STATIONARY PHASE 
Type of Chromatography Mobile Phase Stationary Phase 
Gas chromatography Gas Solid/liquid 
Liquid chromatography Liquid Solid/liquid 
Supercritical-fluid 
chromatography 
Supercritical fluid Solid/liquid 
 
The stationary phase is fixed in place either in column (a hallow tube made out 
of a suitable material, e.g. Glass) or on a planar surface and the mobile phase moves 
over or through the stationary phase carrying with it the sample of interest. In practice 
the stationary phase can be a solid, a liquid adsorbed on a solid or an organic species 
(e.g. A cl8 alkyl chain) bonded to a solid surface. In gas chromatography, 
supercritical-fluid chromatography the stationary phase is fixed in place in a column. 
In liquid chromatography the stationary phase may be fixed in either column or on a 
planar surface. In HPLC a column is used. The name given to liquid chromatography 
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on a planar surface is Thin Layer Chromatography (TLC). (Chatwal R and Anand 
2000). 
The Stationary phase: 
It is the combination of suitable stationary phase and mobile phase that 
enables the separation of mixture and thus analysis of the component in the mixture. 
HPLC is characterized by the use of very small particles of stationary phase which are 
fixed in place in a HPLC column, often made of a material such as stainless steel. 
(ICH Topic Q2B, Nov’1996) 
Normal phase and Reverse phase HPLC: 
In order to describe the different stationary phases available for HPLC it is 
necessary to explain the concept of normal and reverse phase HPLC. These types of 
HPLC vary due to the polarity of the stationary phase and mobile phase in each as 
shown in table below. 
 Stationary phase Stationary Phase 
Normal phase Polar Non- polar 
Reversed phase Non-polar Polar 
 
Normal phase HPLC: 
In a mixture of components to be separated those analytes which are relatively 
more polar will be retained by the polar stationary phase longer than those analytes 
which are relatively less polar. Therefore the least polar component will elute first. 
Chapter - 1                                                                                                  Introduction 
 
Dept. of Pharmaceutical Analysis           9         JKKMMRF College of Pharmacy 
 
 
 
The attractive forces which exist are mostly dipole-dipole and hydrogen bonding 
(polar) interactions. (Indian Pharmacopeia, 2014) 
Reverse phase HPLC: 
In a mixture of components to be separated those analytes which are relatively 
less polar will be retained by the non-polar stationary phase longer than those analytes 
which are relatively more polar. Therefore the most polar component will elute first. 
The attractive forces which exist are mainly non-specific hypdrophobic interactions. 
The exact nature of these interactions is still under discussion.  
Packing/Matrix of the HPLC column: 
The most common packing material used in HPLC columns is silica. It is 
physically robust and chemically stable in virtually all solvents and at low pH (it 
begins to dissolve around pH7). The manufacturing technology for silica production 
has improved substantially since the early days of HPLC. Irregular shaped particles 
contaminated with the metal impurities have given way to spherical particles with low 
levels of impurities. This purer silica is known as type B silica and the less pure pure 
material is known as type A silica. 
Other non-silica based packing's have been introduced in last few years. 
Among them have been polystyrene-de-vinyl benzene polymers, other polymers, 
graphitized carbon and hydroxyapatite. 
The mobile phase: 
The mobile phase for HPLC is the liquid phase which is continually flowing 
through the stationary phase and which carries the analyte through with it. The 
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composition of the mobile phase depends on the nature of the compounds being 
analyzed. The different properties of solvents define whether they are suitable for use 
as a mobile phase either under reversed phase or normal phase conditions. 
The most common solvents used for HPLC are listed below:- 
 N-hexane 
 Methylene chloride 
 Chloroform 
 Methyl-t-butyl ether 
 Tetrahydrofuron (THF) 
 Isopropanol (IPA) 
 Acetonitrile (ACS) 
 Methanol 
 Water 
A blend of two or more of these solvents is used as the mobile phase in a 
HPLC analysis. The proportions of the different solvents in the blend act to adjust the 
polarity of the mobile phase. This is combined with the stationary phase to achieve 
the separation of mixture. Ideally, the components in the mixture will be separated 
fully and will elute within a practical time scale. 
The most important property of the solvent is its ability to interact with both 
ifee stationary phase and the analytes in the mixture, resulting in the desired 
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separation. However, there are other important properties that need to be considered. 
An ideal solvent will be readily available in high purity, relatively inexpensive, safe to 
use routinely and compatible with the entire HPLC system including the detector. 
The HPLC system: 
Instrumentation is required to enable the flow of the mobile phase through the 
stationary phase and also to convert the separated components in to meaningful 
information. A typical configuration of a HPLC system is shown below. 
Components of HPLC system: 
1. Mobile phase reservoir :- Stores the mobile phase required for analysis 
2. Degasser :- Degasses the mobile phase 
3. Pump :- Solvent delivery system, enables the flow of the mobile phase 
through the system 
4. Injector :- Sample delivery system 
5. Column temperature :- Used to control the temperature of the column 
6. Detector :- Detects each component in a separated mixture after it has eluted 
from the column 
7. Data processor :- Converts the data from the detector in to meaningful results 
8. Waste :- Collection of the liquid waste 
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INTRODUCTION TO HIGH PERFORMANCE LC  
 
 
Figure 1: High-Performance Liquid Chromatography [HPLC] System 
 
High  performance  liquid  chromatography  is  now  one  of  the  most  
powerful  tools  in analytical chemistry. It has the ability to separate, identify, and 
quantitate the compounds that  are  present  in  any  sample  that  can  be  dissolved  
in  a  liquid.  Today,  compounds  in trace concentrations as low as parts per trillion 
(ppt) may easily be identified. HPLC can be,  and  has  been,  applied  to  just  about  
any  sample,  such  as  pharmaceuticals,  food, nutraceuticals,   cosmetics,   
environmental   matrices,   forensic   samples,   and   industrial chemicals. 
A high pressure was used to generate the flow required for liquid 
chromatography in packed columns. In the beginning, pumps only had a pressure 
capability of 500 psi. This was called high pressure liquid chromatography, or 
HPLC. 
 
Chapter - 1                                                                                                  Introduction 
 
Dept. of Pharmaceutical Analysis           13         JKKMMRF College of Pharmacy 
 
 
 
ISOCRATIC AND GRADIENT LC SYSTEM OPERATION 
Two basic elution modes are used in HPLC. The first is called isocratic 
elution. In this mode, the mobile phase, either a pure solvent or a mixture, remains 
the same throughout the run. 
The second type is called gradient elution, wherein, as its name implies, the 
mobile phase composition changes during the separation. This mode is useful for 
samples that contain compounds  that  span  a  wide  range  of  chromatographic  
polarity.   
HPLC GRADIENT MIXTURES 
HPLC  gradient  mixers  must  provide  a  very  precise  control  of  solvent  
composition  to maintain a reproducible gradient profile. For low pressure  systems  
this  requires  great  precision  in  the  operation  of  the  miniature  mixing General  
Introduction  valves  used  and  low  dispersion  flows  throughout  the  mixer.  For 
multi-pump high pressure systems it requires a very precise control of the flow rate 
while making very small changes of the flow rate. 
HPLC PUMPS 
Because of the small particles used in modern HPLC, modern LC pumps 
need to operate reliably and precisely at pressures of 10,000 psi or at least 6,000 psi. 
. For analytical purposes HPLC pumps should have flow rates that range from 0 to 
10 ml/min., but for preparative HPLC, flow rates in excess of 100 ml/min may be 
required.  
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HPLC SAMPLE VALVES 
Sample  valves  come  between  the  pump  and  the  column  it  follows  that  
HPLC sample  valves  must  also  tolerate  pressures  up  to  10,000  psi.  For  
analytical  HPLC,  the sample volume should be selectable from sub micro liter to a 
few micro liters, whereas in preparative  HPLC  the  sample  volume  may  be  even  
greater  than  10  ml.   
The valves must deliver a very constant sample size but this is usually 
attained by the use of a constant size sample loop. 
HPLC COLUMNS 
HPLC columns are packed with very fine particles (usually a few microns in 
diameter). The very fine particles are required to attain the low dispersion that give 
the high plate counts expected of modern HPLC. Plate counts in excess of 25,000 
plates per column are possible  with  modern  columns,  however,  these  very  high  
efficiencies  are  very  rarely found  with  real  samples  because  of  the  dispersion  
associated  with  injection  valves, detectors, data acquisition systems and the 
dispersion due to the higher molecular weight of real samples as opposed to the 
common test samples. The main consideration with HPLC is the much wider variety 
of  solvents  and  packing  materials  that  can  be  utilized  because  of  the  much  
lower quantities  of  both  which  are  required.  In  particular  very  expensive  
optically  pure compounds can be used to make Chiral HPLC stationary phases and 
may even be used as (disposable) HPLC solvents. 
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MOBILE PHASE RESERVOIR   
A  reservoir  (Solvent  Delivery)  holds  the  solvent  (called  the  mobile  
phase,  because  it moves). A high-pressure pump solvent manager is used to 
generate and meter a specified flow rate of mobile phase, typically milliliters per 
minute. 
INJECTOR 
An injector (sample manager or auto sampler) is able to introduce (inject) the 
sample into the  continuously  flowing  mobile  phase  stream  that  carries  the  
sample  into  the  HPLC column. The column contains the chromatographic packing 
material needed to effect the separation. This packing material is called the 
stationary phase. 
HPLC DETECTORS  
UV/Vis  spectrophotometers,  including  diode  array  detectors,  are  the  
most  commonly employed    detectors.   Fluorescence    spectrophotometers,    
differential    refractometers, electrochemical  detectors,  mass  spectrometers,  light  
scattering  detectors,  radioactivity detectors or other special detectors may also be 
used. Detector consists of a flow-through cell mounted at the end of the column.  
A beam of UV radiation passes through the flow cell and into the detector. 
As compounds elute from the column, they pass through the cell  and  absorb  the  
radiation,  resulting  in  measurable  energy  level  changes.  Fixed (mercury lamp), 
variable (deuterium or high-pressure xenon lamp), and multi-wavelength detectors 
are widely available. Modern variable wavelength detectors can be programmed to  
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change  wavelength  while  an  analysis  is  in  progress.  Multi-wavelength  
detectors measure  absorbance  at  two  or  more  wavelengths  simultaneously.  
 In  diode  array  multi- wavelength  detectors,  continuous  radiation  is  
passed  through  the  sample  cell,  and  then resolved   into   its   constituent   
wavelengths,   which   are   individually   detected   by   the photodiode  array.  
These  detectors  acquire  absorbance  data  over  the  entire  UV-visible range,   thus   
providing   the   analyst   with   chromatograms   at   multiple,   selectable 
wavelengths, spectra of the eluting peaks and also peak purity. 
Differential refractometers detectors measure the difference between the 
refractive index of  the  mobile  phase  alone  and  that  of  the  mobile  phase  
containing  chromatographic compounds as it emerges from the column.  
Refractive index detectors are used to detect non-UV  absorbing  
compounds.  Fluorimetric  detectors  are  sensitive  to  compounds  that are  
inherently  fluorescent  or  that  can  be  converted  to  fluorescent  derivatives  either  
by chemical  transformation  of  the  compound  or  by  coupling  with  fluorescent  
reagents  at specific functional groups.  
Potentiometric, voltametric, or polarographic electrochemical detectors are 
useful for the quantitation of species that can be oxidized or reduced at a working  
electrode.  These  detectors  are  selective,  sensitive,  and  reliable,  but  require 
conducting   mobile   phases   free   of   dissolved   oxygen   and   reducible   metal   
ions. Electrochemical  detectors  with  carbon-paste  electrodes  may  be  used  
advantageously  to measure   nanogram   quantities   of   easily   oxidized   
compounds,   notably   phenols   and catechols. 
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Many types of detectors can use with HPLC system like UV-Visible or PDA (Photo 
Diode Array), RI (Refractive Index), Fluorescence, ECD (Electro Chemical  
Detector),  ELSD  (Evaporative  Light  Scattering  detector)  and  many others 
hyphenated techniques like MS, MS/MS and NMR as well as evaporative IR. 
DETECTOR USED IN TLC  
UV and spray method: 
Of the three techniques, gas, liquid and thin-layer, TLC is the most universal 
test method as all components are present on the plate and with appropriate detection 
techniques, all components can be observed. However, it normally is not as accurate 
or sensitive as HPLC. TLC has a higher analytical variation than HPLC, although one 
sees the "whole picture" when appropriate detection schemes are selected. 
III. REFERENCE STANDARDS 
A reference standard is a highly purified compound that is well characterized. 
Chromatographic methods rely heavily on a reference standard to provide accurate 
data. Therefore the quality and purity of the reference standard is very important. Two 
types of reference standards, chemical and nuclidic, exist. With the latter, the 
radiolabel purity should also be considered as well as the chemical purity. 
Samples and analytical data for methods Validation, the two categories of 
chemical reference standards are as follows: USP/NF reference standard that does not 
need characterization, and non-compendial standard that should be of the highest 
purity that can be obtained by reasonable effort and should be thoroughly 
characterized to assure its identity, strength, quality and purity. 
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Chromatographic test methods use either external or internal standards for 
quantitation 
A.  An external standard method - is used when the standard is analyzed on 
a separate chromatograrn from the sample. Quantitation is based on a comparison of 
the peak area/height (HPLC or GC) or spot intensity (TLC) of the sample to that of a 
reference standard of the analyte of interest. 
B.  With an internal standard method -- compound of known purity that 
does not cause interference in the analysis is added to the sample mixture. 
Quantitation is based on the response ratio of compound of interest to the internal 
standard vs the response ratio of a similar preparation of the reference standard 
(HPLC or GC). This technique is rarely used for TLC methods; 
The working concentration is the target concentration of the compound of 
interest as described in the method. Keeping the concentrations of the sample and the 
standard close to each other for the external standard method improves the accuracy 
of the method. 
VALIDATION 
Validation is a key process for effective quality assurance. "Validation" is 
established documented evidence, which provides a high degree of assurance that a 
specific process or equipment will consistently produce a product or result meeting its 
predetermined specification and quality attributes. 
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DEFINITIONS BY DIFFERENT AGENCIES: 
1. USFDA defines validation as "establish the documented evidence which 
provides a high degree of assurance that a specific process will consistently 
produce a product of predetermined specifications and quantity attributes". 
2. EUGMP define validation as "action of proving in accordance with the 
principle of Good manufacturing practice (GMP), that any material, activity or 
system actually lead to expected result". 
3. AUSTRALIAN GMP defines validation as "The action of proving that any 
material, process, activity, procedure, system, equipment or mechanism used 
in manufacture or control can and will be reliable and achieve the desire and 
intended result." 
OBJECTIVE OF THE VALIDATION 
1. The primary objective of validation is to form a basis for written procedure for 
production and process control which are designed to assure that the drug 
products have the identity, quality, and purity they purport or are represented 
to possess. 
2. Assurance of Quantity 
3. Government Regulation 
IMPORTANCE OF VALIDATION 
1. As the quality of product cannot always be assured by routine quality control 
because   of resting   of statistically insignificant  number  of  sample,   the 
validation thus should 
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2. Provide adequacy and reliability of a system or product to meet the 
predetermined criteria or attributes providing high degree of confidence that 
the same level of quality is consistently built into each of finished product 
from batch to batch. 
3. Retrospective Validation is useful for trend comparison of results complains to 
cGMP to cGLP. 
4. For taking appropriate action in case of non-compliance. 
TYPES OF VALIDATION 
The following are frequently required to be validated on a pharmaceutical 
process:- 
1. Equipment,   Environment,   Materials,   Methods,   Controls,   Process,   
Personnel's, Facilities and operating procedure. Based on these, the validation 
program comprises. 
2. Equipment Validation 
3. Facility Validation including utilities. 
4. Process Validation 
5. Cleaning Validation 
6. Analytical Method Validation 
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ANALYTICAL METHOD VALIDATION 
Method validation is the process to confirm that the analytical procedure 
employed for a specific test is suitable for its intended use. Analytical testing of a 
pharmaceutical product is necessary to ensure its purity, stability, safety and efficacy. 
Analytical method validation is an integral part of the quality control system. 
Although a thorough validation cannot rule out all potential problems, the process of 
method development and validation should address the most common ones  
 
Define scope of the user's method 
 
Define validation parameters and limits 
 
Standard method fits scope, parameters and limits 
 
Define scope of the user's method 
 
Define validation parameters and limits 
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PARAMETERS USED FOR ASSAY VALIDATION 
The validation of the assay procedure was carried out using the following 
parameters 
SPECIFICITY 
Definition: 
Specificity is the ability to asses unequivocally the analyte in the presence of 
impurities, degradants, matrix etc (components) which may be expected to be present. 
Lack of specificity of an individual analytical procedure may be compensated by 
other supporting analytical procedures. 
Determination: 
The demonstration of specificity requires that the procedure is unaffected by 
the presence of impurities or excipients. In practice this can be done by spiking the 
drug substance or product with appropriate levels of impurities or excipients and 
demonstrating that the assay result is unaffected by the presence of these extraneous 
materials. 
ICH Requirement: 
The ICH documents state that when chromatographic procedures are used, 
representative chromatograms should be presented to demonstrate the degree of 
selectivity, and peaks should be appropriately labeled. Peak purity tests (e.g., using 
diode array or mass spectrometry) may be useful to show that the analyte 
chromatographic peak is not attributable to more than one component. 
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ACCURACY 
Definition:  
The accuracy of an analytical procedure expresses the closeness of agreement 
between the value which is accepted either as a conventional true value or an accepted 
reference value and the value found. 
Determination: 
In case of assay of a drug in a formulated product, accuracy may be 
determined by application of the analytical method to synthetic mixtures of the drug 
product components to which the known amount of analyte have been added within 
the range of the method. If it is not possible to obtain all drug product components, it 
may be acceptable either to add known quantities of the analyte to the drug product or 
to compare results with those of a second, well characterized method, the accuracy of 
which has been stated or defined. Accuracy is the measure of how close the 
experimental value is to the true value. Accuracy studies for drug substance and drug 
product are recommended to be performed at the 80, 100 and 120% levels of label 
claim as stated in the Guideline for Submitting Samples and Analytical Data for 
Methods Validation. For the drug product, this is performed frequently by the addition 
of known amounts of drug by weight or volume (dissolved in diluent) to the placebo 
formulation working in the linear range of detection of the analyte. This would be a 
true recovery for liquid formulations. For formulations such as tablet, suppository, 
transdermal patch, this could mean evaluating potential interaction of the active drug 
with the excipients in the diluent. From a practical standpoint, it is difficult to 
manufacture a single unit with known amount of active drug to evaluate recovery. 
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This test evaluates the specificity of the method in the presence of the excipients 
under the chromatographic conditions used for the analysis of the drug product. It will 
pick up recovery problems that could be encountered during the sample preparation 
and the chromatographic procedures. However, it does not count the effect of the 
manufacturing process. At each recommended level studied, replicate samples are 
evaluated. The RSD of the replicates will provide the analysis variation or how 
precise the test method is. The mean of the replicates, expressed as % label claim, 
indicates how accurate the test method is. 
ICH Requirement: 
The ICH documents recommended that accuracy should be assessed using a 
minimum of nine determinations over a minimum of three concentration levels, 
covering the specified range (i.e., three concentrations and three replicates of each 
concentration. 
PRECISION 
Definition: 
The precision of an analytical procedure expresses the closeness of agreement 
between a series of measurements obtained from multiple sampling of the same 
homogenous sample under the prescribed conditions. The precision of an analytical 
procedure is usually expressed as the variance, standard deviation or coefficient of 
variation of a series of measurements. 
Precision can be categorized into two types as follows, 
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System precision: 
A system precision is evaluated by measuring the peak response for six 
replicate injection of the same standard solution prepared as per the proposed method. 
The RSD is calculating it should not be more than 2%. 
Method precision: 
A method precision is evaluated by measuring the peak response for six 
replicate injection of six different weight of sample solution prepared as per the 
proposed method. The RSD is calculating it should not be more than 2%. 
Determination: 
The precision of an analytical method is determined by assaying a sufficient 
number of aliquots of a homogenous sample to be able to calculate statistically valid 
estimates of standard deviation or relative standard deviation. 
ICH Requirement: 
The ICH documents recommended that repeatability should be assessed using 
a minimum of nine determinations covering the specified range for the procedure (i.e., 
three concentrations and three replicates of each concentration or using a minimum of 
six determinations at 100% of the test concentration). 
LINEARITY 
Definition: 
The linearity of an analytical procedure is its ability (within a given range) to 
obtain the test results which are directly proportional to the concentration (amount) of 
analyte in the sample 
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Linearity of an analytical procedure is established, using a minimum of five 
concentrations. It is established initially by visual examination of a plot of signals as a 
function of analyte concentration of content. If there appears to be a linear 
relationship, test results are established by appropriate statistical methods, (i.e. by 
calculation of a regression line by the method of least squares). 
ICH Requirement: 
ICH recommends that, for the establishment of linearity, a minimum of five 
concentrations normally be used. It is also recommended that the following minirnum 
specified ranges should be considered Assay of drug substance (or a finished product) 
from 80% to 120% of the test concentration. 
LIMIT OF DETECTION (LOD) 
Definition: 
LOD is the lowest concentration of the substance that the method can detect 
but not necessarily quantify. LOD simply indicates that the sample is below or above 
a certain level. 
Determination: 
For non-instrumental methods, the detection limit is generally determined by 
the analysis of samples with known concentrations of analyte and by establishing the 
minimum level at which the analyte can be reliably detected. 
ICH Requirement: 
The ICH describes a common approach, which is to compare measured signal 
from samples with known low concentrations of analyte with those of blank samples. 
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The minimum  concentration   at which  the  analyte  can  reliably  be  detected   is 
established. Typically acceptable signal-to-noise ratios are 2:1 or 3:1. 
Measurement is based on: 
Signal to noise ratio 
Visual evaluation (relevant chromatogram acceptable) 
The standard deviation of the response and the slope. 
    3.3 
 LOD =   
      S 
 
Where, 
 - The standard deviation of the response 
S - The slope of the calibration curve (of the analyte) 
LIMIT OF QUANTITATION (LOQ) 
Definition: 
LOQ is the lowest concentration of the substance that can be estimated 
quantitatively with acceptable precision, accuracy and reliability by the proposed 
method. LOQ is determined by analysis of samples containing decreasing known 
quantity of the substance and determining the lowest level at which acceptable level 
of accuracy and precision is attained. 
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Determination: 
For non-instrumental methods, the quantization limit is generally determined 
by the analysis of samples with known concentrations of analyte and by establishing 
the minimum level at which the analyte can be determined with acceptable accuracy 
and precision 
ICH Requirement: 
The ICH describes a common approach, which is to compare measured signal 
from samples with known low concentrations of analyte with those of blank samples. 
The minimum concentration at which the analyte can reliably be quantified is 
established. Typically acceptable signal-to-noise ratios are 10:1. 
    10 
 LOQ =   
      S 
Where,  
 - The standard deviation of the response 
S - The slope of the calibration curve (of the analyte) 
RANGE 
Definition: 
The range of an analytical procedure is the interval between the upper and 
lower concentration (amounts) of anlayte in the sample (including these 
concentrations) for which it has been demonstrated that the analytical procedure has a 
suitable level of precision, accuracy and linearity. 
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Determination: 
The range of the method is validated by verifying that the analytical method 
provides acceptable precision, accuracy and linearity when applied to samples 
containing analyte at the extremes of the range as well as within the range. 
ROBUSTNESS: 
Definition: 
The robustness of an analytical procedure is a measure of its capacity to 
remain unchanged by small but deliberate variations in method parameters and 
provides an indication of its reliability during normal usage. 
Determination: 
The robustness of method is determined by performing the assay by 
deliberately altering parameters (change in flow rate ±10%, change in mobile phase 
ratio of ±2, change in pH of mobile phase ±0.2, change in wave length detection 
±5nm, change in temperature ± 1 to 5°) that the results are not influenced by the 
changes in the above parameters. 
RUGGEDNESS: 
Definition: 
The ruggedness of an analytical method is the degree of reproducibility of test 
results obtained by the analysis of the same samples under a variety of conditions, 
such as different laboratories, different analysts, different instruments, different lots of 
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reagents, different elapsed assay times, different assay temperatures, different days, 
etc. 
Determination: 
The Ruggedness of an analytical method is determined by the analysis of 
aliquots from homogeneous lots in different laboratories, by different analysts, using 
operational and environmental condition that may differ but are still within the 
specified parameters of the assay. The degree of reproducibility of the result is then 
determined as a function of assay variables. This reproducibility may be compared to 
the precision of assay under normal condition to obtain a measure of the ruggedness 
of the analytical method. 
SAMPLE SOLUTION STABILITY: 
Solution stability of the drug substance or drug product after preparation 
according to the test method should be evaluated according to the test method. Most 
laboratories utilize auto samplers with overnight runs and the sample will be in 
solution for hours in the laboratory environment before the test procedure is 
completed. This is of concern especially for drugs that can undergo degradation by 
hydrolysis, photolysis or adhesion to glassware. 
SYSTEM SUITABILITY SPECIFICATIONS AND TESTS 
The accuracy and precision of HPLC data collected begin with a well behaved 
chromatographic system. The system suitability specifications and tests are 
parameters that provide assistance in achieving this purpose. It consists of following 
factors.                                                           . 
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1.   Capacity factor. 
2.   Precision/injection repeatability 
3.   Relative retention 
4.   Resolution 
5.   Tailing factor 
6.   Theoretical plate number. 
1. CAPACITY FACTOR (k’) 
K’ = (tR - tO) / tf 
The capacity factor is a measure of where the peak of interest is located with 
respect to the    void volume, i.e., elution time of the non-retained components. 
 
2. Precision/Injection repeatability (RSD) 
Injection precision expressed as RSD (relative standard deviation) indicates 
the performance of the HPL chromatograph which includes the plumbing, column, 
and environmental conditions, at the time the samples are analyzed. It should be noted 
that sample preparation and manufacturing variations are not considered. 
3. Relative retention () 
 = k’l / k'2 
Relative retention is a measure of the relative location of two peaks. This is 
not an essential parameter as long as the resolution (Rs) is stated. 
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4. Resolution (Rs) 
Rs==(tR2-tR1) / (l/2) (tw1 + tw2) 
Rs is a measure of how well two peaks are separated. For reliable quantitation, 
well-separated peaks are essential for quantitation. This is a very useful parameter if 
potential interference peak(s) may be of concern. 
5. Tailing factor (T) 
T = Wx/2f 
The accuracy of quantitation decreases with increase in peak tailing because of 
the difficulties encountered by the integrator in determining where/when the peak 
ends and hence the calculation of the area under the peak. Integrator variables are 
preset by the analyst for optimum calculation of the area for the peak of interest. If the 
integrator is unable to determine exactly when an upslope or down slope occurs, 
accuracy drops. 
6. Theoretical plate number (N) 
N= 16(tR / tW)2 = L/H 
Theoretical plate number is a measure of column efficiency, that is, how many 
peaks can be located per unit run-time of the chromatogram. 
Where,  
N  -  Constant for each peak on a chromatogram with a fixed set of operating 
conditions. 
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H  -  Height equivalent of a theoretical plate. 
L  -  Length of column. 
PAPER CHROMATOGRAPHY 
 Paper chromatography is a technique that involves placing a small dot or line 
of sample solution onto a strip of chromatography paper. The paper is placed in a jar 
containing a shallow layer of solvent and sealed. As the solvent rises through the 
paper, it meets the sample mixture which starts to travel up the paper with the 
solvent. This paper is made of cellulose, a polar substance, and the compounds 
within the mixture travel farther if they are  non-polar.  More  polar  substances  
bond  with  the  cellulose  paper  more  quickly,  and therefore do not travel as far. 
THIN LAYER CHROMATOGRAPHY 
 Thin  layer  chromatography  (TLC)  is  a  widely  employed  laboratory  
technique  and  is similar to paper chromatography. However, instead of using a 
stationary phase of paper, it  involves  a  stationary  phase  of  a  thin  layer  of  
adsorbent  like  silica  gel,  alumina,  or cellulose on a flat, inert substrate. For even 
better resolution and to allow for quantification, high-performance TLC can be used. 
TECHNIQUES BY PHYSICAL STATE OF MOBILE PHASE 
GAS CHROMATOGRAPHY 
 Gas chromatography (GC), also sometimes known as Gas-Liquid  
chromatography, (GLC), is a separation technique in which the mobile phase is a 
gas. Gas chromatography is always carried out in a column, which is typically 
"packed" or "capillary". 
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 Gas chromatography (GC) is based on a partition equilibrium of analyte 
between a solid stationary  phase  (often  a  liquid  silicone-based  material)  and  a  
mobile  gas  (most  often Helium). 
 The stationary phase is adhered to the inside of a small-diameter glass tube (a 
capillary column) or a solid matrix inside a larger metal tube (a packed column). It is 
widely used in analytical chemistry; though the high temperatures used in GC make 
it unsuitable for high  molecular  weight  biopolymers  or  proteins  (heat  will  
denature  them),  frequently encountered in biochemistry, it is well suited for use in 
the petrochemical, environmental monitoring,  and  industrial  chemical  fields.  It  is  
also  used  extensively  in  chemistry research. 
LIQUID CHROMATOGRAPHY 
 Liquid  chromatography  (LC)  is  a  separation  technique  in  which  the  
mobile  phase  is  a liquid. Liquid chromatography can be carried out either in a 
column or a plane. Present day  liquid  chromatography  that  generally  utilizes  
very  small  packing  particles  and  a relatively high pressure is referred as high 
performance liquid chromatography (HPLC). 
 In  the  HPLC  technique,  the  sample  is  forced  through  a  column  that  is  
packed  with irregularly or spherically shaped particles or a porous monolithic layer 
(stationary phase) by  a  liquid  (mobile  phase)  at  high  pressure.  HPLC  is  
historically  divided  into  two different sub-classes based on the polarity of the 
mobile and stationary phases. Technique in  which  the  stationary  phase  is  more  
polar  than  the  mobile  phase  (e.g.  toluene  as  the mobile   phase,   silica   as   the   
stationary   phase)   is   called   normal   phase   liquid chromatography  (NPLC)  and  
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the  opposite  (e.g.  water-methanol  mixture  as  the  mobile phase and C18 = 
octadecylsilyl as the stationary phase) is called reversed phase liquid 
chromatography (RPLC). Ironically the "normal phase" has fewer applications and 
RPLC is therefore used considerably more. 
AFFINITY CHROMATOGRAPHY 
 Affinity chromatography is based on selective non-covalent interaction 
between an analyte and specific molecules. It is often used in biochemistry  in  the  
purification  of  proteins  bound  to  tags.  These  fusion  proteins  are labeled with 
compounds such as His-tags, biotin or antigens, which bind to the stationary phase  
specifically.  After  purification,  some  of  these  tags  are  usually  removed  and  
the pure protein is obtained. Affinity chromatography often utilizes a biomolecule's 
affinity for a metal (Zn, Cu, Fe, etc.). Immobilized Metal Affinity Chromatography 
(IMAC) is useful to separate aforementioned molecules based on the relative affinity 
for the metal (I.e. Dionex IMAC).  
SUPERCRITICAL FLUID CHROMATOGRAPHY 
 Supercritical fluid chromatography is a separation technique in which the 
mobile phase is a fluid above and relatively close to its critical temperature and 
pressure. 
Buffer selection 
 Choice of buffer is typically governed by the desired pH. The typical pH range 
for reversed-phase on silica-based packing is pH 2 to 8. It is important that the buffer 
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has a pKa close to the desired pH since buffer controls pH best at their pKa. A rule is 
to choose a buffer with a pK a value <2 units of the desired mobile phase pH(Table-1). 
Table-1: HPLC Buffers, pKa Values and Useful pH Range 
Buffer pKa Useful pHRange 
Ammonium acetate 4.8 3.8-5.8 
Ammonium formate 3.8 2.8-4.8 
KH2PO4/ phosphoricacid 2.1 1.1-3.1 
KH2PO4/K2PO4 7.2 6.2-8.2 
Potassium Acetate/ aceticacid 4.8 3.8-5.8 
Borate(H3BO3/Na2B4O710H2O) 9.2 8.2-10.2 
Ammonium hydroxide/ammonia 9.2 8.2-10.2 
Trifluoroacetic acid <2 1.5-2.5 
Potassium formate/formic acid 3.8 2.8-4.8 
 
Buffer concentration 
 Generally, a buffer concentration of 10-50mM is adequate for small 
molecules. Generally, no more than 50% organic should be used with a buffer. This 
will depend on the specific buffer as well as its concentration. Phosphoric acid and its 
sodium or potassium salts are the most common buffer systems for reversed-phase 
HPLC. 
Selection of detector 
Detector is a very important part of HPLC. Selection of detector depends on 
the chemical nature of analytes, potential interference, limit of detection required, 
availability and/ or cost of detector. UV-Visible detector is versatile, dual-
wavelength absorbance detector for HPLC. This detector offers the high sensitivity 
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Photodiode Array (PDA) Detector offers advanced optical detection for Waters 
analytical HPLC, preparative HPLC, orLC/MS system solutions. Refractive 
Index(RI) Detector offers high sensitivity, stability and reproducibility, which make 
this detector the ideal solution for analysis of components with limited or no UV 
absorption. Multi-Wavelength Fluorescence Detector offers high sensitivity and 
selectivity fluorescence detection  for quantitating low concentrations of target 
compounds. 
Column selection 
The heart of a HPLC system is the column. Changing a column will have the 
greatest effect on there solution of analytes during method development. Generally, 
modern reverse phase HPLC columns are made by packing the column housing with 
spherical silica gel beads which are coated with the hydrophobic stationary phase. The 
stationary phase is introduced to the matrix by reacted a chlorosilane with the hydroxyl 
groups present on the silica gel surface. There are several types of matrices for suppor 
to the stationary phase, including silica, polymers, and alumina. Silica is the most 
common matrix for HPLC columns. The nature, shape and particle size of the silica 
support  effects separation. Smaller particle results in a greater number of the oretical 
plates, or increased separation efficiency. Common stationary phases are 
C4(butyl),C8(octyl),C18(octadecyl),nitrile(cyanopropyl),andphenyl(phenylpropyl)colu
mns. In general, longer alkyl chains, higher phase loading, and higher carbon loads 
provide greater retention of non-polar analytes. Commonly used reverse phase columns 
and their uses are listed below. Propyl(C3), Butyl(C4), and Pentyl(C5) columns are 
useful for ion-pairing chromatography. Examples: include ZorbaxSB-C3,YMC-
PackC4, and LunaC5. These columns are generally less stable to hydrolysis than 
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columns with longer alkyl chain. Octyl(C8)columns have wide applicability. This 
phase is less retentive than the C18phases, but is still quite useful for pharmaceuticals. 
Example:include(ZorbaxSB-C8,LunaC8andYMC-Pack-MOS). Octadecyl (C18,ODS) 
columnsare themost widelyusedandtendtobethemostretentivefornon-polaranalytes. 
Examples include ZorbaxSB-C18,YMC-PackODS and Luna C18. Xterra RP-C18 and 
Zorbax Extend-C18 columns have been formulated to tolerate high pH systems 
(pH>7,normallyuptopH11).  
Column temperature 
Column temperature control is important for long-term method 
reproducibility as temperature can affects electivity. A target temperature in the 
range of 30–40°C is normally sufficient for good reproducibility. Use of elevated 
temperature can be advantageous for several reasons. The temperature may also 
affect selectivity patterns because analytes will respond dissimilarly to different 
temperatures. An increase of 1°C will decrease the k' by1to2%, a both ionic and 
neutral samples are reported to show significant changes in a with temperature 
changes. Possible temperature fluctuations during method development and 
validation, it is recommended that the column be thermostated to control the 
temperature. 
Mobile phase Solvent type 
Solvent type (methanol, acetonitrile and tetrahydrofuran) will affect 
selectivity. The choice between methanol and acetonitrile may be dependent on the 
solubility of the analyte as well as the buffer used. Tetrahydrofuran is least polar 
among these three solvent, often responsible for large changes in selectivity and is 
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also incompatible with the low-wavelength detection required for most 
pharmaceutical compounds. 
Typically a10–50mM solution of an aqueous buffer is used. The most 
commonly used aqueous phase is H3PO4 in water i.e.phosphatebuffer. The pH of a 
phosphate buffer is easily adjusted by using mono-, di-, ortribasic phosphate salts. 
However, when phosphate salts are used the solution should be filtered to remove 
insoluble particles with 0.22 µm filter paper. Other non-UV active acids and bases 
may also be used to effect differences in peak shape and retention. 
pH of Mobile phase 
When the sample is eluted with a mobile phase with 100% organic there is no 
separation, as the sample is eluted in the void volume. This is because the sample is not 
retained; but retention is observed when the mobile phase solvent strength is decreased 
to allow equilibrium competition of the molecules between the bonded phase and the 
mobile phase. When these parathion is complex, that is, many components are to be 
separated, and when the solvent strength is decreased and there is still no resolution 
between two close peaks, another organic solvent of a different polarity or even a 
mixture of two organics may need to be tried to effect separation. Additionally, mobile 
phase optimization can be enhanced incombination with bonded phase optimization 
(i.e., substituting C18/ C8 with cyanoorphenyl). A goal for the band spacing of a solute 
(K’) should be in the range of 4to9and a run time of about15minutes or20minutes at 
most for most routine product release or stability runs. 
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Separation Techniques 
Isocratic separations: Isocratic, constant eluent composition means 
equilibrium conditions in the column and the actual velocity of compounds moving 
through the column are constant; analyte eluent and analyte-stationary-phase inter 
actions are also constant throughout the whole run. This makes isocratic separations 
more predictable, although these parathion power (the number of compounds which 
could be resolved) is not very high. The peak capacity is low; and the longer the 
component is retained on the column, the wider is the resultant peak. 
Gradient separation: Gradient separation significantly increases the 
separation power of a system mainly because of the dramatic increase of the apparent 
efficiency (decrease of the peak width). The condition where the tail of a 
chromatographic zone is always under the influence of a stronger eluent composition 
leads to the decrease of the peak width. Peak width varies depending on the rate of the 
eluent composition variation (gradient slope).  
Changing Gradient: Gradient elution is employed for complex 
multicomponent samples since it may not be possible to get all components eluted 
between k(retention factor) 1and10 using a single solvent strength under isocratic 
conditions. This leads to the general elution problem where no one set of conditions is 
effective in eluting all components from a column in a reasonable time period while 
still at taining resolution no feach component. Employing gradients shall owor steep 
allows for obtaining differences in the chromatographic selectivity. This would be 
attributed to the different slopes of the retention versus organic composition for each 
analyte in the mixture. 
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Sample preparation for method development 
The drug substance being analyzed should be stable in solution (diluent). 
During initial method development, preparations of the solutions in amber flasks 
should be performed until it is determined that the active component is stable at room 
temperature and does not degrade under normal laboratory conditions. The sample 
solution should be filtered ;the use of a 0.22  or 0.45µm pore-size filter is generally 
recommended for removal of particulates. Filtration is a preventive maintenance tool 
for HPLC analysis. 
Sample preparation is a critical step of method development that the analyst 
must investigate. The effectiveness of the syringe filters is largely determined by 
their ability to remove contaminants/ insoluble components without leaching  
undesirable artifacts (i.e., extractable) into the filtrate. If any additional peaks are 
observed in the filtered samples, then the diluents must be filtered to determine if a 
leachable component is coming from the syringe filter housing/ filter. 
Method Optimization 
The experimental conditions should be optimized to get desired separations 
and sensitivity after getting appropriate separations. Stability indicating assay 
experimental conditions will be achieved through planned/ systemic examination on 
parameters including pH (if ionic), mobile phase components and ratio, gradient, 
flow rate, temperature, sample amounts, Injection volume and diluents solvent type. 
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Method Validation 
Validation of analytical procedure is the process by which it is established ,by 
laboratory studies, that the performance characteristics of the procedure meet the 
requirements for its intended use. The methods validation process for analytical 
procedures begins with the planned and systematic collection by the applicant of the 
validation data to support analytical procedures. All analytical methods that are 
intended to be used for analyzing any clinical samples will need to be validated. The 
validation of analytical methods is done as per ICH guidelines. 
Validation parameters 
The following are typical analytical performance characteristics which may be 
tested during methods validation: 
 Accuracy 
 Precision 
 Repeatability 
 Intermediate precision 
 Linearity 
 Detection limit 
 Quantitation limit 
 Specificity 
 Range 
 Robustness 
 System suitability determination 
 Forced degradation studies 
 Stability studies
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2. LITERATURE REVIEW 
1. Simultaneous determination of ofloxacin and ornidazole in 
pharmaceutical dosage by reverse phase high performance liquid 
chromatography  
 The  method  was  determined  for  simultaneous determination  of  
ofloxacin  and  ornidazole  from  combined  dosage  form.  The  separation  of  
drug  was achieved  on  Zorbax  Eclipse  C18  (250  x  4.6  mm  i.d.)  with  5  µ  
particle  size. The mobile phase consisted of a mixture of buffer and acetonitrile 
(65:35 % (v/v)).  The  buffer was  0.03  M  disodium  hydrogen  phosphate 
solution  adjusted  the  pH  3.2  with  ortho- phosphoric  acid.  The  detection  was  
carried  out  at  wavelength  284  nm.  The  mixture  of  buffer  of  pH  3.2  and 
acetonitrile (65:35% v/v) was used as a diluent. The method was validated for 
system suitability, linearity, accuracy, precision, robustness, stability of sample 
solution. The method has been successfully used to analyze ofloxacin and 
ornidazole from combined dosage form. (Rele. Rajan V. et. al., 2015) 
2. Simultaneous determination of ofloxacin and ornidazole in solid dosage form 
by RP-HPLC and HPTLC techniques 
 A chromatographic method developed and validated for simultaneous 
determination of ofl oxacin and ornidazole in solid dosage form. The method was 
based on reversed phase high performance liquid chromatography, on Intersil C18 
column (250 mm, 4.6 i.d.), using acetonitrile:methanol: 0.025M phosphate buffer, 
pH 3.0 (30:10:60 % v/v/v) as the mobile phase, at a fl ow rate of 1 ml/min at ambient 
temperature. Quantifi cation was achieved with UV detection at 318 nm over a 
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concentration range of 2-40 μg/ml for ofl oxacin and 5-100 μg/ml for ornidazole. The 
mean retention time of ofl oxacin and ornidazole was found to be 4.04 min and 5.83 
min, 6.77 min (isomers), respectively. The amount of ofl oxacin and ornidazole 
estimated as percentage of label claimed was found to be 100.23 and 99.61%, with 
mean percent recoveries 100.20 and 100.93%, respectively. (Puranik Manisha, 
et.al., 2014) 
3. Method development andvalidation for the simultaneous estimation of 
ofloxacin and ornidazole in tablet dosage form by rp-hplc 
A  simple  reverse  phase  liquid  chromatographic  method  has  been  
developed  and  subsequently validated for simultaneous determination of Ofloxacin 
and Ornidazole in combination. The separation was carried out  using  a  mobile  
phase  consisting  of  2mM  phosphate  buffer  and  Acetonitrile  with  pH  3.5  
adjusted  with  ortho phosphoric acid in the ratio of 70: 30%v/v. The column used 
was Phenomenex C18,  (250 mm x 4.6 mm i.d, 5m) with flow rate of 1 ml / min 
using PDA detection at 293 nm. The described method was linear over a 
concentration range of 5-50 g/ml and 12.5-125 g/ml for the assay of Ofloxacin and 
Ornidazole respectively. Gatifloxacin (50g/ml) was used as internal standard. The 
retention times of Ofloxacin, Ornidazole and Gatifloxacin were found to be  2.1, 2.5  
and  5.5min  respectively.  Results  of  analysis  were  validated  statistically  and by  
recovery  studies.  The limit of detection (LOD) and the limit of quantification 
(LOQ) for Ofloxacin and Ornidazole were found to be 5 and10 µg/ml 10 and 25 
µg/ml respectively. (Dhandapani B. et. al., 2010) 
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4.  Development and validation of a method for simultaneous estimation of 
ofloxacin and ornidazole in different dissolution media 
A spectrophotometric method was developed for determination of ofloxacin 
and ornizole in bulk and in pharmaceutical preparations. The method is based on the 
formulation in buffer pH 6.8 and 7.4 for ofloxacin and ornidazole respectively. The 
drugs were quantitatively measured at 294 and 287 nm for ofloxacin and ornidazole 
respectively. (Patel Dasharath M. et. al., 2012) 
Recovery Studies of drug mixture- 
  
5. Development of uv-spectrophotometric method for the quantitative estimation 
of ofloxacin and ornidazole in combined liquid oral dosage form by simultaneous 
equation method 
A simple, sensitive and accurate UV-Spectrophotometric method for the 
quantitative estimation of Ofloxacin and Ornidazole in bulk and combined liquid 
oral  dosage form has been developed and  validated.  Methanol  was  used  as  a  
solvent  for  estimation  of  ofloxacin  and  ornidazole  in combined liquid dosage 
form. Both the standard solutions were scanned over the range of 400-200   nm   
in   spectrum   mode   of   spectrophotometer   at   medium   scanning   speed   
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using   U.V spectrophotometer. The maximum absorbance for Ofloxacin and 
Ornidazole was found  at  295.6  nm  and  310.8  nm  respectively. Ofloxacin  and  
Ornidazole  were  found  to  be  in  the  range  of  99.58  –100.69 % and 99.86 – 
101 %, respectively. The results of analysis were validated statistically. (Gandhi 
V.M. et. al., 2013) 
6. Simultaneous Estimation of Ciprofloxacin Hydrochloride, Ofloxacin, 
Tinidazole and Ornidazole by Reverse Phase – High Performance Liquid 
Chromatography 
An assay has been developed for simultaneous estimation of Ofloxacin  and  
Ornidazole  in  tablet  formulations.  The  separation  was achieved  by  using  C-18  
column  (Phenomenax,  250  x  4.6mm  i.d.) in mobile phase Acetonitrile: Water: Tri 
ethylamine (25:75). The pH of mobile phase was adjusted to 6.0 ± 0.1 with 50% 
ortho phosphoric acid. The flow rate was 1.0 mL.min-1  and the separated drugs 
were detected using UV detector at the wavelength of 300 nm. The retention time of  
Ofloxacin and Ornidazole was noted to be 3.5 and 5.8 min, respectively. The method 
was validated as per ICH guidelines.  The  proposed  method  was  found  to  be  
accurate,  reproducible,  and  consistent.  It  was successfully applied for the analysis 
of these drugs in marketed formulations.  (Singh Ranjit et. al., 2009) 
7. Development & validation of RP-UPLC method for simultaneous estimation of 
ofloxacin and ornidazole in their combine dosage form including stress study  
A RP-UPLC method was developed  for the analysis of Ofloxacin and 
Ornidazole in  combined infusion form. The sample was analyzed by RP-UPLC 
instrument using  reverse phase C18 column (Purospher Star 100×2.1 mm, Merck  
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Specialities)  as  stationary  phase  and  Phosphate  Buffer:  Acetonitrile  (70:30  v/v)  
as  a  mobile  phase [where PH  of of the buffer was adjusted to 2.5 by using Tri ethyl 
amine (1ml / lit buffer) and ortho-phosphoric acid] at a flow rate of 0. 4 ml/min. TUV 
detector was used for the detection at 294 nm. The retention time for Ofloxacin and 
Ornidazole was found to be 0.648 and 1.158 minute respectively.  (Manan Sevak et. 
al., 2010) 
8. Simultaneous Determination and Validation of Ofloxacin and Ornidazole in 
Combined Dosage Pharmaceutical Formulation  
The method was carried out on a Xterra TM ® RP18, 5 µm (4.6 X250mm) 
column with a mobile phase consisting of acetonitrile : mixed phosohate buffer 
[0.21012% (w/v) KH2PO4 and 0.10852% (w/v) K2HPO4, in HPLC grade water and 
pH is adjusted to 3.0 with 10% potassium hydroxide solution.] in the ratio 40 : 60. 
The flow rate was 1.0 ml/min and the effluent was monitored for ofloxacin at 294 nm 
and for ornidazole at 305 nm (Waters 2487 dual absorbance detector).The retention 
time of ofloxacin and ornidazole was 2.84 min and 4.39 min respectively. Percentage 
recoveries for Ofloxacin and Ornidazole were 99.54% to 97.60% and 99.77% to 
98.47% respectively. The validation of the proposed method was also carried out in 
terms of linearity, accuracy, precision,symmetry factor, plate count, regression, and 
recovery. (Ghosh Soumya Jyoti et. al., 2009) 
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9. Development And Validation Of UV Spctrophotometric method for 
determination of Ofloxacin and Ornidazole in combined dosage form using 
smultanious equation method  
A simple, precise UV spectrophotometric method has been developed for  
determination of ofloxacin and ornidazole in its tablet dosage form by using distilled 
water as a solvent. The absorption maximum (λ max) was observed at 287 nm and 
318 nm respectively. The method obeys beer lamberts linearity in the range of 2-12 
ug/ml for ofloxacin and 5- 30 ug/ml for ornidazole with a value of correlation 
coefficient (R 2 ) 0.999 for both the drugs at their respective wavelength. Assay was 
performed on two different brands of marketed formulation. Precision studies were 
carried out as per ICH guidelines Q2 R1and were found to be within the limits NMT 2 
% concluding that the method is precise. The proposed method can be used for 
routine purity testing in bulk and combined dosage forThe UV study was carried out 
to determine OFX and ORN by simultaneous equation method in combined dosage 
form. The objective of this method was to develop a simple precise and reproducible 
method to analyse both the drugs for routine use. The method was developed using 
distilled water as a solvent. It involved formation of simultaneous equations using 287 
nm and 318 nm as the wavelengths. (Absorption maxima of both the drugs).The 
absorptivity values (A 1% 1cm) were calculated at both the wavelengths (287 nm and 
318 nm). An attempt was made to develop a simple, accurate, precise and economical 
simultaneous equation method for quantitative determination of OFX and ORN in 
pharmaceutical tablet dosage form. The optimized method was validated according to 
ICH guidelines Q2 R1. (Farrel Lisa Gauncar and Sachi S. Kudchadkar, 2009) 
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10. RP- HPLC Method for Simultaneous Estimation of Ofloxacin and 
Ornidazole from Bulk and Tablets  
A simple, selective, rapid, precise and economical reverse phase high-pressure 
liquid chromatographic method has been developed for the simultaneous estimation of 
Ofloxacin and Ornidazole from pharmaceutical formulation. The method was carried 
out on a Kromasil C18(5mm, 25 cm X 4.6 mm,i.d.) column, with a mobile phase 
consisting acetonitrile: phosphate buffer (pH 2.4) in the ratio 80: 20% V/V at a flow 
rate of 1.0 ml/min. Detection was carried out at 294 nm. The retention time of 
Ofloxacin and Ornidazole were 2.773 and 5.448min respectively. The developed 
method was validated in terms of accuracy, precision, linearity, Limit of detection, 
Limit of quantitation. The proposed method can be used for estimation of these drugs 
in combined dosage form for routine analysis. The assay was validated according to 
ICH guideline. The proposed method was found to be simple and linear in the 
concentration range of 20 to 100 mg/ml for Ofloxacin and 25 to 125mg/ml for 
Ornidazole respectively. The method was found to be accurate and precise as 
indicated by recovery studies and % RSD not more than 1.5. Moreover LOD and 
LOQ Ofloxacin were found to be 0.002 mg/ml and 0.0061 mg/ml, respectively and 
for Ornidazole were 0.091mg/ml and 0.2768 mg/ml, respectively. Thus the method is 
specific and sensitive. (RS Jadhav, et.al., 2009) 
11. Method Development and Validation for Simultaneous Estimation of 
Ofloxacin and Ornidazole In Bulk and Pharmaceutical Dosage forms  
A simple, rapid, sensitive reverse-phase high-performance liquid 
chromatography method was developed and validated for simultaneous estimation of 
ofloxacin and ornidazole, at single wavelength of 343nm.chromotographic separation 
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was performed on an enable aligent zorabax(thermo) column(250nmx4.6mm ID 
particle size 5 um) and a mobile phase consisting of acetonitrile and buffer 
(600:4300v/v) at a flow rate of 1.0ml/min. the calibration curve was linear (r2 
≥0.0999) over the concentration range. 400-1200μg/mL of ofloxacin and 1000-
3000μg/mL of ornidazole. the limit of detection 0.00246µg/ml for ofloxacin 
0.00508µg/ml for ornidazole and no interference was found by the excipients in the 
synthetic mixture. The proposed methods were validated for international conference 
on harmonization guideline for linearity, accuracy, precision, and robustness for 
estimation of ofloxacin and ornidazole in bulk and synthetic mixture, and The results 
were found to be satisfactory. A new high performance liquid chromatographic 
method has been developed and validated for the simultaneous determination of 
ofloxacin and ornidazole in pure and tablet formulations. It was observed from the 
validation results that the developed RP-HPLC method is more sensitive, accurate, 
precise, repeatable with wide range of linear range as compared to the reported 
method4 .The run time of the present assay is relatively short i.e. less than 10 min, 
which enable rapid quantitation of samples in the routine analysis of tablet 
formulation.. Basing on the above aspects it is concluded that the developed RP-
HPLC method can be used for the simultaneous determination of ofloxacin and 
ornidazole in tablet formulations. (Challa Sudheer, et.al., 2016) 
12. Spectrophotometric Method for Simultaneous Estimation of Atorvastatin 
and Amlodipine in Tablet Dosage Form  
Atorvastatin is an anti hyperlipo proteinemic drug and amlodipine is an 
antihypertensive drug. A simple, precise, rapid and selective spectrophotometric 
method has been developed for the simultaneous determination of atorvastatin and 
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amlodipine in tablet dosage forms. The method involves solving of simultaneous 
equations based on measurement of absorptivity at two wavelengths 242nm and 
364nm. Linearity range for atorvastatin and amlodipine were 1-20μg/ml and 1-
50μg/ml respectively. (Lakshmana Rao et al., 2010) 
13. Simultaneous determination of Amlodipine besylate and Atorvastatin 
calcium in tabletd osage forms by spectrophotometric methods 
A simple, accurate, precise and reproducible UV spectrophotometric method 
was developed for simultaneous estimation of Amlodipine besylate (AMD) and 
Atorvastatin calcium (ATR) in tablet dosage form have been developed. First method 
is simultaneous equation method; in this method 361nm and 246 nm were selected to 
measure the absorbance of drugs at both wavelengths. The second method is Q-value 
analysis based on measurement of absorptivity at 238.8 nm (as an iso-absorptive 
point) and 246 nm. AMD and ATR at their respective maximum wavelength 361 nm 
and 246 nm and at isoabsorptive point 238.8 nm shows linearity in a concentration 
range of 0.5-30 μg/mL. Recovery studies range from&gt;99.82% for AMD and 
&gt;98.09% for ATR in case of simultaneous equation method and &gt;100% for 
AMD and&gt;98.45% for ATR in case of Q-analysis method confirming the accuracy 
of the proposed method. The proposed methods are recommended for routine analysis 
since it is rapid, simple, accurate and also sensitive and specific. (no heating and no 
organic solvent extraction is required.) (Talluri Chandrashekar et al., 2010) 
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3. OBJECTIVES AND AIM OF THE WORK 
The ever increasing number of drugs and their combinations in the market 
leads to the need for the development of analytical methods for their quality control. 
The methods have to be such that it takes less time in their development as well as the 
best accurate and robust results should be obtained. Based on this concept the aim of 
the research work was to develop novel analytical methods with the aid of statistical 
approach such as chemo metrics and Quality by Design and to further extend this 
study to applicability of these methods. 
Antibacterials such as Ofloxacin, class of fluroquinolones  and  Ornidazole, 
class of nitroimmidazole, are being prescribed  and  used worldwide for their broad  
spectrum activity. Ofloxacin by inhibits the super coiling activity of DNA gyrase 
halting DNA replicant. Most anaerobic pathogens and  several Gram positive strains 
such as Staphylococci and Streptococci are only moderately susceptible to Ofloxacin. 
Thus in some clinical situations a combination with other antibacterial agent is 
needed to broaden antibacterial spectrum. Ornidazole drug belonging to the class of 
nitroimmidazole has antibacterial spectrum  that  includes most anaerobes. This is 
said to  involve interference with DNA by a metabolite in which nitro group has been 
reduced. Single dose Ornidazole is an important alternative agent for the treatment of 
many conditions, other than nitroimmidazoles. 
Most of the pharmaceuticals industries rely upon quantitative chemical 
analysis to ensure that the raw material used and the final product thus obtained meet 
certain specifications and to determine how much component is present in the final 
product. 
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The number of drug and drug formulations introduced into the market has 
been increasing at an alarming rate. Standard analytical procedures for these drugs or 
formulations may not be available and if available may not suit to our actual 
conditions of use. So it is required to develop newer analytical methods which are 
accurate, precise, specific, linear, simple and rapid. 
The modern methods of choice of assays are High-pressure Liquid 
Chromatography (HPLC), which requires highly sophisticated equipment, trained 
personnel, high purity chemicals and proper maintenance. 
Literature review reveals that only limited work has been done on 
simultaneous estimation of these drugs. So in the present work, an effort is being 
made to develop a newer method of analysis of these drugs in combination with other 
drugs and evaluated as per ICH guide lines. HPLC is a modern technique which is 
more reliable, reproducible method for the standardization of both single and 
combined dosage form. Developed method will then be useful for their simultaneous 
determination in bulk as well as dosage form. 
Our present work aims to develop a new and specific, precise, accurate, linear, 
simple rapid and cost effective HPLC method for the simultaneous estimation of  
Ofloxacin and Ornidazole in the liquid dosage form. The scope of our work extend to 
validate for the developed methods. 
 The developed method is validated for parameters such as system suitability, 
precision, accuracy, linearity, ruggedness and robustness and evaluation of analytical 
method validation report generated for the developed methods as per ICH guidelines.        
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 The aim is “Simultaneous Estimation and Validation of Ofloxacin And 
Ornidazole by RP-HPLC Method” and the validation by the developed methods 
as  per ICH guidelines. 
Every drug or drug substance should match certain specifications and to 
determine how much component is present in the final product. 
The number of drug and drug formulations introduced into the market has  
Standard analytical procedures for these drugs or formulations may not be available 
and if available may not suit to our actual conditions of use. So it is required to 
develop newer analytical methods which are simple, easy to available, accurate, 
precise, specific, linear and rapid. 
The modern methods of choice of assays are High-pressure Liquid 
Chromatography (HPLC), which requires highly sophisticated equipment, trained 
personnel, high purity chemicals and proper maintenance and gives very good results 
with accuracy and fastly. 
As the aim according to literature survey few analytical methods were 
reported using Phosphate buffer and acetonitrile and water as solvent. The present aim 
is to develop new analytical method to estimate the Ofloxacin and Ornidazole in its 
combined dosage form. As the drug is polar in nature, it was proposed to select RP-
HPLC method.  
Method development includes the development of initial chromatographic 
conditions, setting up and optimization of developed chromatographic conditions for 
the assay of Ofloxacin and Ornidazole. 
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The developed method is validated for parameters such as system suitability, 
precision, accuracy, linearity, ruggedness and robustness and evaluation of analytical 
method validation report generated for the developed methods as per ICH guidelines.        
PLAN OF WORK 
i) Study of physicochemical properties of drug, (pH, pKa, solubility and 
molecular weight) 
ii) Preparation of drug standard and sample,  
iii) Optimization chromatographic conditions like, 
a. Selection of wavelength 
b. Selection of initial separation conditions 
c. Nature of stationary phase  
d. Nature of mobile phase (pH, solvent strength, solvent ratio and 
flowrate) 
iv) Study of system suitability parameters, 
v) Validation of proposed method by RP-HPLC  
vi) Applying developed method to marketed formulation.      
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Review of Literature 
 
Study of physicochemical 
properties of drug and 
establishment of detection 
wavelength 
              
 
HPLC Trials with different 
conditions 
 
Optimization of the HPLC method 
 
Method validation for the above 
developed HPLC method 
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4. DRUG PROFILE  
OFLOXACIN 
Ofloxacin (OFL) is a fluoroquinolone derivative. Chemically, it is (±)-9-
fluoro-2, 3-dihydro-3-methyl10- (4-methyl-1-piperazinyl)-7-oxo-7H-pyrido-[1,2,3- 
de]- 1,4-benzoxazine -6-carboxylic acid. It is mainly used as antibacterial for the 
treatment of urinary tract infection and sexually transmitted diseases. Ofloxacin is 
characterized by a good pharmacokinetic profile. Following oral administration, there 
is rapid and extensive oral absorption from the gastrointestinal tract achieving peak 
serum concentration within 1 – 3 h and levels in excess of 100g/ml in the urine and 
bladder . It is used in the treatment of urinary tract, prostate, skin, urinary and 
respiratory tract infections. It is also used to treat certain sexually transmitted 
diseases. Ofloxacin is used as an antibacterial agent in the treatment of infections 
caused by a wide range of both Gram-positive and Gram-negative bacteria as well as 
Chlamydia infections.  
 
Ofloxacin is an antibiotic that is used to treat bacterial infections. It belongs to  
thefluoroquinolone class of antibiotics which includes levofloxacin (Levaquin), 
ciprofloxacin (Cipro), gatifloxacin (Tequin), norfloxacin (Noroxin), moxifloxacin 
(Avelox), trovafloxacin (Trovan) and others. Ofloxacin stops the multiplication of 
bacteria by inhibiting the reproduction and repair of their genetic material (DNA). 
The FDA approved ofloxacin in  December 1990.Ofloxacin is a synthetic, broad 
spectrum first generation bactericidal fluoroquinolone. (Dasharath M.Patel, 2012) 
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DRUG   NAME                         : OFLOXACINE 
STRUCTURE                            :     
N
(R)O
O
OH
O
N
N
F
(E)
 
CHEMICAL NAME                   : 
                                                         
(RS)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-
oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene
-11-carboxylic acid                                                                     
MOLECULAR WEIGHT  :  361.3675 gm/mole 
MELTING POINT                       : 254 °C 
MOLECULAR FORMULAE     : C18H20FN3O4 
SOLUBILITY                              : Soluble in Water 
CATEGORY                               :   Antibacterial and anti-infective. 
MECHANISM OF ACTION      :  Ofloxacin acts on DNA gyrase and 
toposiomerase IV, enzymes which, like huan 
topoisomerase, prevents the excessive 
supercoiling of DNA during replication or 
transcription. By inhibiting their function, the 
drug thereby inhibits normal cell division.   
ABSORPTION                     :  Bioavailability of ofloxacin in the    tablet                                           
formulation is approx 98% 
PROTEIN BINDING                 : 32% 
METABOLISM                          :    Hepatic  
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DRUG PROFILE 
ORNIDAZOLE 
Ornidazole is a 5-nitroimidazole derivative and is used in the treatment of 
susceptible protozoal infections and also in anaerobic bacterial infections. It has been 
used for amebic liver abscesses, duodenal ulcers, giardiasis, intestinal lambliasis and 
vaginitis. Ornidazole has recently been used with success in patients with active 
Crohn’s disease. It is more effective against amebiasis than metronidazole, which is 
the most commonly used nitroimidazole derivative in therapy12- 14. Ornidazole has 
also been preferred for surgical prophylaxis because of its longer elimination half-life 
and excellent penetration into lipidic tissues versus other nitroimidazole derivatives. 
Ornidazole is used in combination with Ofloxacine in the tretment of PLD and in 
intra-abdominal infection. In this present communication we reports two simple, 
accurate, and most economical methods for simultaneous estimation of ornidazole and 
ofloxacin in combained dosage forms. Fixed dose combination of Ornidazole 500 mg 
and Ofloxacin 200 mg is available in the tablets form in the market. The present work 
describes a simple, precise and accurate reversed phase HPLC method for the 
simultaneous estimation of Ornidazole and Ofloxacin in combined dosage form. The 
method was validated according to procedures and acceptance criteria based on FDA 
guidelines and recommendations of ICH. 
 
Ornidazole is a antibiotic used to treat some protozoaninfections. It has also 
been investigated  for use in Crohn's diseaseafter bowel resection. (Gandhi V.M, 
et.al., 2013) 
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DRUG   NAME                    : ORNIDAZOLE 
STRUCTURE                         :  
                                                                    HO
N
N
N+ O
-O
Cl
 
IUPAC NAME                     : 1-chloro-3-(2-methyl-5-nitro-1H-imidazol-1-
yl)propan-2-ol  
MOLECULAR WEIGHT       : 219.63 gm/mole 
MOLECULAR FORMULAE     : C7H10 ClN3O3  
CATEGORY                       :  Antibiotic, Antiprotozoal. 
MECHANISM OF ACTION     : After passive abortion into bacterium cell, the 
nitro group of ornidazole is reduced into an 
amine group by redox intermediate intracellular 
metabolites is believed to be the key component 
responsible for killing micro-organism. 
CONTRAINDICATIONS      : Neurological disease blood dyscrasias first 
trimester of pregnancy hypersensitivity, caution 
in chronic alcoholics                          . 
ADVERSE EFFECTS    : G.I. discomfort, Pain in abdomen, Virtigo                                                                                    
Skin rash, Headache.  
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5. MATERIALS AND METHODS 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
TECHNIQUE 
 MATERIALS USED 
Instruments employed: 
1. Digital balance    Wenser                                 
2. pH Meter     Digital pH meter Instrument india                                 
3. Sonicator     Ultrawave, instrument india 
4. Membrane filter    Nylon membrane filter (0.45µ) 
5. HPLC SHIMADZU-LC 20 AT                                  
           a. Software used   LC Solution 
           b. Detector    UV-detector 
           c. Analytical column   Agilent C18 (250x4.6mm) 5µ  
6. UV SHIMADZU-UV -Visible Spectrophotometer 
           a. Instrument Model   UV-1800                                                         
           b. Instrument Type   UV -1800PC Series 
           c. Software Name & Version  UV prove 2.21 Version  
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 CHEMICALS  USED  
 Ofloxacin working reference standard              AR grade 
Ornidazole working reference Standard  AR grade 
Potassium dihydrogen phosphate   AR grade 
Acetonitrile      HPLC grade                                                 
Ortho phosphoric acid    HPLC grade                                                  
Water milli-Q grade     HPLC grade        
 TABLETS BRAND USED: MEDLEY Pharmaceuticals 
Trial – 1:  
 The trial 1 was performed using mobile phase Acetonitrile and buffer in the 
ratio 50 : 50 Agilent C18 (250 x 4.6 mm) 5m packing with flow rate 2 ml / min. 
ofloxacin peak splited.  
Trial – 2:  
 The trial 2 was performed using mobile phase acetonitrile and buffer in the 
ratio 80 : 20 Agilent C18 (250 x 4.6 mm) 5  ofloxacin peak splited with flow rate 
splited (0.1 ml/min.) 
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Trial – 3:  
 The trial 3 was performed using mobile phase sodium acetate and buffer in the 
ratio 55 : 45 agilent C18 (250 x 4.6mm) 5  packing with flow rate 0.1 ml/min. 
ofloxacin and onidazole peak splited. 
Trial – 4:  
 The trial 4 was performed using mobile phase ortho phosphoric acid and 
buffer in the ratio 20 : 80 v/v agilent C18 (250 x 4.6mm) 5  packing with flow rate 
0.1 ml/min ofloxacin and onidazole peak splited. 
Trial – 5:  
 The trial 5 was performed using mobile phase acetonitrile  buffer in the ratio 
50 : 50 agilent C18 (250 x 4.6mm) 5  packing with flow rate 0.2 ml/min onidazole 
peak splited. 
Trial – 6:  
 The trial 6 was performed using mobile phase acetonitrile and buffer in tetra 
hydro furan in the ratio 35 : 64.9 (pH = 3.5) agilent agilent C18 (250 x 4.6mm) 5  
packing with flow rate 1.0 ml/min ofloxacin peak good separation. 
 METHOD DEVELOPMENT  
Optimization of mobile phase: 
 Separation of both the drugs was tried using the following combination of 
mobile phases. The table gives the details of the same  
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Table No. 1 Method development trails 
Serial no. Mobile phase Ratio (v/v) Elution of peak 
1. Buffer : Acetonitrile 50 : 50 
Not proper 
separation 
2. Buffer : Acetonitrile 80: 20 
Not proper 
separation 
3. 
Buffer : [ Sodium 
Acetate:Methanol : 
Acetonitrile  5:40 : 55 v/v] 
55:45 Separation of peaks 
4. 
Buffer : [Orthophosphoric acid 
Acetonitrile :  20 : 80 v/v] 
20 : 80 Separation of peaks 
5. 
Buffer : [Acetonitrile :  
Orthophosphoric acid 50:50 
v/v] 
50 : 50 Separation of peaks 
6. 
Buffer : [Acetonitrile : 
Tetrahydrofuron 35:64.9 v/v] 
Adjust pH with 
Orthophosphoric acid 
35-64.9  Good Separation 
 
 Out of 6 trials the 6th trial was selected for further studies because when 
compared to other trails 5th trial was found less in retention time due to the ratio or 
organic solvent in mobile phase.  
Selection of Wavelength 
         Solution of Ofloxacin and ornidazole were scanned in the UV region and 
spectrum was recorded (200-400nm). The solvent used was Buffer: [Acetonitrile : 
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Tetrahydrofuron 35:64.9 v/v] Adjust pH with Orthophosphoric acid in ratio of 
35:64.9. It was seen that 300nm both compounds have very good absorbance, which 
can be used for the estimation of compounds by HPLC.  
Selection of Chromatographic Method 
 Proper selection of the method depends on the nature of the sample (ionic or 
ionisable or neutral molecules), its molecular weight, pKa value and stability. The 
drugs selected in the present study are polar and so reversed phase or ion exchange 
chromatography can be used. The reversed phase HPLC was selected for the initial 
separation because of its simplicity and suitability. 
 From the literature survey and with the knowledge of properties of the selected 
drugs, Aligent C-18 (250x4.6mm) 5µ column was chosen  as stationary phase and 
mobile phase with different compositions such as Potassium dihydrogen phosphate 
buffer and Acetonitrile was used. 
 From all the data observed, obtained, available the initial separation conditions 
were set to work around. 
Effect of Ratio of Mobile Phase 
 Under the chromatographic conditions mentioned above, the different ratios of 
mobile phase were tried. The chromatograms were observed for each of the trails, out 
of which Buffer : (Acetonitrile & Sodium acetate & methanol  - 55:45 v/v) in the ratio 
of 50:50 was selected as the separation was achieved in minimum retention time. 
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Effect of pH of Mobile Phase 
 Several trials were made using different Buffer solutions of different pH 
range. The best separation was achieved with Potassium dihydrogen phosphate adjust 
the pH to 3.5 ± 0.1 with dil. Orthophosphoric acid.  
Effect of flow rate on separation 
 The mobile phase consisting of Buffer : [Acetonitrile : Tetrahydrofuron 
35:64:1 v/v]  and the chromatograms were recorded at flow rates of 0.5ml to 2ml. The 
sharp peaks were obtained with 1 ml flow rate.  
Effect of column (Stationary phase) on separation 
 At the chromatographic conditions of mixed solutions, combinations of 
Ofloxacin and Ornidazole were injected and chromatograms were obtained using C-
18 column, so C-18 was preferred for further studies.  
Reference Standards 
 Keeping the all above fixed conditions External standard was used.  
Optimized Conditions 
 The following optimized parameters were used as a final method for the 
simultaneous estimation of Ofloxacin and Ornidazole. 
Instrument   : SHIMADZU – LC 2010                                  
Column   : Agilent C18 (250x4.6mm) 5µ  
Column Oven Temperature : 30º C  
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Wave length   : 300nm 
Flow rate   : 1.0ml/min                                     
Injection Volume  : 20µl 
Runtime   : 8 minutes  
Mode of Operation  : Reverse phase 
     Mobile Phase  
Solvent A   : (Potssium dihydrogen phosphate Buffer  
  &   Tetra hydro furan 64:01 v/v) 
Solvent B   : (Acetonitrile– 35 v/v)                      
Solvent ratio   : 64.9 v/v of Solvent A:B 
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METHOD OF VALIDATION BY – HPLC 
 SYSTEM SUITABILITY : 
Preparation of standard stock solution: 
Ofloxacin: 
 Weigh and transfer accurately 50 mg of Ofloxacin working standard into a 
100ml clean and dry volumetric flask and make up with 100ml of diluent and sonicate 
to dissolve.  
Ornidazole: 
 Weigh and transfer accurately 62.5mg of Ornidazole working standard into a 
50ml clean and dry volumetric flask and make up with 50ml of diluent and sonicate to 
dissolve.  
Preparation of standard solution: 
 Taken 1.5 ml from above standard stock solution in a 50 ml volumetric flask 
and diluted with make phase. 
Procedure:  
 System suitability of the method was performed by calculating the parameters 
namely, resolution and number of theoretical plates on the 10 replicate injection of 
standard solution into HPLC system and calculated. 
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 SYSTEM SUITABILITY : 
 System suitability testing is an integral part of many analytical procedures. The 
tests are based on the concept that the equipment, electronics, analytical 
operations, and samples to be analyzed constitute an integral system that can be 
evaluated as such. System suitability test parameters to be established for a 
particular procedure depend on the type of procedure being validated. See 
pharmacopoeias for additional information. System suitability tests are an integral 
part of gas and liquid chromatographic methods. They are used to verify that the 
resolution and reproducibility of the chromatographic system are adequate for the 
analysis to be done. The tests are based upon the concept that the equipment, 
electronics, analytical operations and samples to be analysed constitute an integral 
system that can be evaluated as such. It goes on to mention resolution, column 
efficiency and peak symmetry as measurements that can be made but it makes no 
recommendation as to requirements for these parameters. 
 The tests are based on the concept that the equipment, electronics, analytical 
operations, and samples analyzed constitute an integral system that can be 
evaluated as such. Factors that may affect chromatographic behavior include the 
following: • Composition, ionic strength, temperature, and apparent pH of the 
mobile phase • Flow rate, column dimensions, column temperature, and pressure • 
Stationary phase characteristics, including type of chromatographic support 
(particle-based or monolithic), particle or macropore size, porosity, and specific 
surface area • Reverse-phase and other surface modification of the stationary 
phases, the extent of chemical modification (as expressed by end-capping, carbon 
loading, and others) RS is a function of the number of theoretical plates, N (also 
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referred to as efficiency), a, and k. [NOTE—All terms and symbols are defined in 
Definitions and Interpretation of Chromatograms.] For a given stationary phase 
and mobile phase, N may be specified to ensure that closely eluting compounds 
are resolved from each other, to establish the general resolving power of the 
system, and to ensure that internal standards are resolved from the drug. This is a 
less reliable means to ensure resolution, as opposed to direct measurement. 
Column efficiency is, in part, a reflection of peak sharpness, which is important 
for the detection of trace components. Replicate injections of a standard 
preparation or other standard solutions are compared to ascertain whether 
requirements for precision are met. Unless otherwise specified in the individual 
monograph, data from five replicate injections of the analyte are used to calculate 
the relative standard deviation (RSD), if the requirement is £2.0%; data from six 
replicate injections are used if the RSD requirement is >2.0%. .System suitability 
of method was performed by calculating the chromatographic parameters like 
column efficiency, resolution, and asymmetric factor on the repetitive injection of 
standard solution32 . Stability studies 33, 34 The stability studies give an evidence 
for the variation of quality of drug product under the influence of various 
environmental factors such as temperature, humidity and light. The international 
conference of harmonization (ICH) has developed the guideline for stability of 
new drug substance and product. This guideline gives an idea about the stability 
data package required for registration. Main aim of carrying out the stability 
studies was to determine the re-test of the drug substance, establishing the shelf 
life of the drug products and recommending the proper storage condition of the 
drug product for long term storage and use. As a whole the stability studies are 
very much essential because the physical, chemical and microbial variation may 
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cause a high degree of impact on the efficiency and security of the final drug 
product.  
Table No.2 Result System suitability  
Inj no. Ofloxacin Ornidazole 
 RT  Area Response RT  Area Response 
1 3.422 1663620 6.077 1688288 
2 3.422 1656669 6.077 1688288 
3 3.422 1653464 6.077 1688288 
4 3.42 1646650 6.07 1688288 
5 3.45 1642172 6.12 1689818 
6 3.45 1660286 6.12 1693663 
7 3.45 1642172 6.124 1685784 
8 3.45 1642172 6.124 1682558 
9 3.42 1643618 6.07 1685834 
10 3.42 1641914 6.077 1688036 
Average  1649273.7  1687884.5 
STD  7388.3  18955 
%RSD  0.447  1.12 
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Acceptance Criteria: 
The %RSD for 10 replicate injections should not more than 2.0% 
 The system suitability parameters and % RSD for peak areas for 10 replicate 
injections of standard solution was found to be within limits. 
 SPECIFICITY 
 Specificity is the ability to assess unequivocally the analyte in the presence of 
components that may be expected to be present such as impurities, degradation 
products and matrix components. 
 Chromatogram of blank solutions showed no peaks at the retention times of 
Ofloxacin and Ornidazole. This indicates that the solvents and chemicals used in the 
formulated do not interfere in estimation of Ofloxacin and ornidazole in the Tablets. 
An investigation of specificity should be conducted during the validation of 
identification tests, the determination of impurities, and the assay. The procedures 
used to demonstrate specificity will depend on the intended objective of the analytical 
procedure. It is not always possible to demonstrate that an analytical procedure is 
specific for a particular analyte (complete discrimination). In this case, a combination 
of two or more analytical procedures is recommended to achieve the necessary level 
of discrimination. Suitable identification tests should be able to discriminate between 
compounds of closely related structures which are likely to be present. The 
discrimination of a procedure may be confirmed by obtaining positive results (perhaps 
by comparison with a known reference material) from samples containing the analyte, 
coupled with negative results from samples which do not contain the analyte. In 
addition, the identification test may be applied to materials structurally similar to or 
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closely related to the analyte to confirm that a positive response is not obtained. The 
choice of such potentially interfering materials should be based on sensible scientific 
judgment with a consideration of the interferences that could occur. For 
chromatographic procedures, representative chromatograms should be used to 
demonstrate specificity, and individual components should be appropriately labeled. 
Similar considerations should be given to other separation techniques. Critical 
separations in chromatography should be investigated at an appropriate level. For 
critical separations, specificity can be demonstrated by the resolution of the two 
components which elute closest to each other. In cases where a nonspecific assay is 
used, other supporting analytical procedures should be used to demonstrate overall 
specificity. For example, where a titration is adopted to assay the drug substance for 
release, the combination of the assay and a suitable test for impurities can be used. 
Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. Lack of specificity of an individual analytical 
procedure may be compensated by other supporting analytical procedure(s). This 
definition has the following implications: Identification: To ensure the identity of an 
analyte. Purity Tests: To ensure that all the analytical procedures performed allow an 
accurate statement of the content of impurities of an analyte, i.e., related substances 
test, heavy metals, residual solvents content, etc. Assay (content or potency): To 
provide an exact result which allows an accurate statement on the content or potency 
of the analyte in a sample  
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Table No.3 Specificity data 
Name of Peak Retention time (Interferences) 
Diluent No time Peak Observed (No interference) 
Mobile Phase No time Peak Observed (No interference) 
Ofloxacin  3.4 minutes (No interference) 
Ornidazole 6.1 minutes(No interference) 
Acceptance Criteria: 
 Diluent and Mobile Phase should not show any interference at the retention 
time corresponding to the peak of Ofloxacin and Ornidazole calcium. 
Preparation of Standard Stock solution:  
Ofloxacin: 
 Weigh and transfer accurately 50 mg of Ofloxacin working standard into a 
100ml clean and dry volumetric flask and make up with 100ml of diluent and sonicate 
to dissolve.  
Ornidazole: 
 Weigh and transfer accurately 62.5mg of Ornidazole working standard into a 
50ml clean and dry volumetric flask and make up with 50ml of diluent and sonicate to 
dissolve.  
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Sample Solution 
 Weighed and finely powdered not less than 20 tablets. Transferred an 
accurately weighed portion of the powder of ofloxacin about 100mg  and  Ornidazole 
about 250mg in 200ml volumetric flak, added 100ml of diluant phase sonicated for 30 
minutes. Make up the volume with diluant. Mixed well and filtered through 0.45µ 
nylon filter paper discarded first few ml of the filtrate.  
Acceptance Criteria  
 There should not be any interference from blank and diluents solution.  
Results for Specificity: 
S.NO. Solutions Retention time  
Peak 
Purity 
1 Diluent - - 
2 Blank - - 
3 Ofloxacin  and Ornidazole Std. 3.42 and 6.077 Pass 
4 Blank - - 
5 Ofloxacin  and Ornidazole Sample 3.422 and 6.07 Pass 
 LINEARITY : 
 Appropriate aliquots of (0.5, 1, 1.5, 2 & 2.5ml) two drug combination were 
pipette out from the stock solution into a series of 50ml volumetric flasks. The 
volume was made up to the mark with Makeup phase.  Inject 20µl of each 
concentration into the HPLC system and chromatographed under the optimized 
conditions. Evaluation was performed with the UV detector set at 300 nm and the 
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peak areas were recorded. The linearity of an analytical procedure is its ability (within 
a given range) to obtain test results which are directly proportional to the 
concentration (amount) of analyte in the sample. The linearity of an analytical 
procedure is its ability (within a given range) to obtain test results which are directly 
proportional to the concentration (amount) of analyte in the sample.A linear 
relationship should be evaluated across the range (see section 3) of the analytical 
procedure. It may be demonstrated directly on the drug substance (by dilution of a 
standard stock solution) and/or separate weighings of synthetic mixtures of the drug 
product components, using the proposed procedure. The latter aspect can be studied 
during investigation of the range. Linearity should be evaluated by visual inspection 
of a plot of signals as a function of analyte concentration or content. If there is a linear 
relationship, test results should be evaluated by appropriate statistical methods, for 
example, by calculation of a regression line by the method of least squares. In some 
cases, to obtain linearity between assays and sample concentrations, the test data may 
have to be subjected to a mathematical transformation prior to the regression.analysis. 
Data from the regression line itself may be helpful to provide mathematical estimates 
of the degree of linearity. The correlation coefficient, y-intercept, slope of the 
regression line, and residual sum of squares should be submitted. A plot of the data 
should be included. In addition, an analysis of the deviation of the actual data points 
from the regression line may also be helpful for evaluating linearity. Some analytical 
procedures, such as immunoassays, do not demonstrate linearity after any 
transformation. In this case, the analytical response should be described by an 
appropriate function of the concentration (amount) of an analyte in a sample. For the 
establishment of linearity, a minimum of five concentrations is recommended. Other 
approaches should be justified.  
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Procedure for preparation of standard stock solution 
Ofloxacin: 
 Weigh and transfer accurately 50 mg of Ofloxacin working standard into a 
100ml clean and dry volumetric flask and make up with 100ml of diluent and sonicate 
to dissolve.  
Ornidazole: 
 Weigh and transfer accurately 62.5mg of Ornidazole working standard into a 
50ml clean and dry volumetric flask and make up with 50ml of diluent and sonicate to 
dissolve.  
STOCK SOLUTION 
 
 
   0.5/50 ml M.P.           1/50ml M.P.          1.5/50 ml M.P.      2/50mlM.P.     2.5/50 ml  
            M.P.H2O 
(Oflox)  5 g                 10g                15 g              20 g              25 g 
(Ornda)  12.5  g          25g              37.5 g               50g              62.5g 
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Table No.4 Linearity of Ofloxacin 
Conc. (g/ml) Area Response Avg. Area response 
5 
478739 
476859.33 478306 
473533 
10 
936507 
936179.33 931496 
940535 
15 
1432153 
1429202 1429294 
1426159 
20 
1924976 
1929383.67 1938199 
1924976 
25 
2479720 
2479720 2479720 
2479720 
 Correlation coefficient 1.012 
 
Acceptance Criteria: 
The Correlation Co-efficient should be NLT 0.999 for peak. 
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Table 
No.4 Linearity of Ornidazole 
Conc. (g/ml) Area Response Avg. Area response 
5 
479517 
477763.66 476887 
476887 
10 
982284 
979891.33 973366 
984042 
15 
1442213 
1438605 1438700 
1434902 
20 
1913053 
1913053 1913053 
1913053 
25 
2339249 
2330328.67 2327417 
2324320 
 Correlation coefficient 1.110 
 
Acceptance Criteria: 
 The Correlation Co-efficient should be NLT 0.999 for peak. 
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 ROBUSTNESS:  
 The evaluation of robustness should be considered during the development 
phase and depends on the type of procedure under study. It should show the 
reliability of an analysis with respect to deliberate variations in method 
parameters. If measurements are susceptible to variations in analytical 
conditions, the analytical conditions should be suitably controlled or a 
precautionary statement should be included in the procedure. One 
consequence of the evaluation of robustness should be that a series of system 
suitability parameters (e.g., resolution test) is established to ensure that the 
validity of the analytical procedure is maintained whenever used. Examples of 
typical variations are: • Stability of analytical solutions • Extraction time In the 
case of liquid chromatography, examples of typical variations are: • Influence 
of variations of pH in a mobile phase • Influence of variations in mobile phase 
composition • Different columns (different lots and/or suppliers) • 
Temperature • Flow rate In the case of gas-chromatography, examples of 
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typical variations are: • Different columns (different lots and/or suppliers) • 
Temperature • Flow rate  
 The robustness of an analytical procedure is a measure of its capacity to 
remain unaffected by small, but deliberate variations in method parameters 
and provides an indication of its reliability during normal usage.  
 The evaluation of robustness should be considered during the development 
phase and depends on the type of procedure under study. It should show the 
reliability of an analysis with respect to deliberate variations in method 
parameters. If measurements are susceptible to variations in analytical 
conditions, the analytical conditions should be suitably controlled or a 
precautionary statement should be included in the procedure. One 
consequence of the evaluation of robustness should be that a series of system 
suitability parameters (e.g., resolution test) is established to ensure that the 
validity of the analytical procedure is maintained whenever used. Examples of 
typical variations are: • stability of analytical solutions, • extraction time In the 
case of liquid chromatography, examples of typical variations are • influence 
of variations of pH in a mobile phase, • influence of variations in mobile phase 
composition, • different columns (different lots and/or suppliers), • 
temperature, flow rate. In the case of gas-chromatography, examples of typical 
variations are • different columns (different lots and/or suppliers), • 
temperature, • flow rate. 
 Robustness  is the ability of the procedure to provide analytical  results of 
acceptable accuracy and precision under a variety of conditions. The results 
from separate samples are influenced by changes in the operational or 
environmental conditions.  Robustness should be considered during the 
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development phase and should show the reliability of an analysis when 
deliberate variations are made in method parameters.  
 Both the ICH and the USP guidelines define the robustness of an analytical 
procedure as a measure of its capacity to remain unaffected by small but 
deliberate variations in procedural parameters listed in the documentation, 
providing an indication of the method's or procedure's suitability and 
reliability during normal use. But while robustness shows up in both 
guidelines, interestingly enough, it is not in the list of suggested or typical 
analytical characteristics used to validate a method (again, this apparent 
discrepancy is changing in recently proposed revisions to USP. 
 Robustness traditionally has not been considered as a validation parameter in 
the strictest sense because usually it is investigated during method 
development, once the method is at least partially optimized. When thought of 
in this context, evaluation of robustness during development makes sense as 
parameters that affect the method can be identified easily when manipulated 
for selectivity or optimization purposes. Robustness measures the capacity of 
an analytical method to remain unaffected by small but deliberate variations 
in method parameters. It also provides some indication of the reliability of an 
analytical method during normal usage. Parameters that should be 
investigated are percent organic content in the mobile phase, pH of the mobile 
phase, buffer concentration, temperature, and injection volume. These 
parameters may be evaluated one factor at a time or simultaneously as part of 
a factorial experiment  
 Solution Stability: 
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            Stability of solution is ascertained by determining peak area difference of 
sample solution at different time intervals with respect to initial results.   
Table no. 9  Solution stability data 
Time in hours 
AMD ATV 
% Assay % Difference % Assay % Difference 
Initial hour     
12hrs     
24hrs     
 
                               (Initial value in hour)    –   (Difference value in hour)    
% Difference   =  ------------------------------------------------------------------------   x 100 
                                                     (Initial value in hour)  
 
Acceptance Criteria: 
 The %Assay should be with in 98% to 102%  
 The %Difference should be NMT 2.0 
Result: 
From the above results, it can be concluded that the standard and sample 
solution is stable for least 24hrs. 
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Table No.10 Ruggedness  
%RSD from six replicate 
injection of sample 
INSTRUMENTS EMPLOYED 
HPLC Instrument SHIMADZU 
(System-1) 
WATER ALLIANCE 
(System-2) 
Column C-18 Aligent 
(250x4.6mm) 5 µm 
C-8 Phenomenex 
(250x4.6mm) 5 µm 
Resolution 11.432 10.288 
%RSD Ofloxacin 0.7120 0.2512 
%RSD Orndazole 0.5882 0.4661 
 
 PRECISION :  
System precision: 
 System precision was done by using Ofloxacin and Ornidazole combination of 
concentration 15 µg/ml each, prepared six times and injected into the HPLC system 
under the optimized conditions. The precision of an analytical procedure expresses the 
closeness of agreement (degree of scatter) between a series of measurements obtained 
from multiple sampling of the same homogeneous sample under the prescribed 
conditions. Precision may be considered at three levels: repeatability, intermediate 
precision and reproducibility. Precision should be investigated using homogeneous, 
authentic samples. However, if it is not possible to obtain a homogeneous sample it 
may be investigated using artificially prepared samples or a sample solution. The 
precision of an analytical procedure is usually expressed as the variance, standard 
deviation or coefficient of variation of a series of measurements.Precision is the 
degree of agreement among individual results. The complete procedure  should be 
applied repeatedly to separate, identical samples drawn from the same homogeneous  
batch of material. It should be measured by the scatter of individual results from the 
mean and expressed as the relative standard deviation (RSD).  
Chapter - 5                                                                               Materials and Methods 
 
Dept. of Pharmaceutical Analysis           87         JKKMMRF College of Pharmacy 
 
 
 
Table No.6 System Precision data 
Sample 
no. 
Ofloxacin Ornidazole 
RT Area response Avg. RT Area response Avg. 
1. 3.45 1668516 
1654190.67 
6.12 1699345 
1692889 
3.45 1667827 6.12 1696777 
3.45 1660286 6.124 1693663 
3.45 1644171 6.124 1691947 
3.45 1642172 6.12 1689818 
3.45 1642172 6.12 1685784 
2 3.45 1668747 
1667145 
6.124 1708789 
1701134.33 
3.45 1668747 6.124 1705747 
3.45 1668747 6.12 1702485 
3.45 1668516 6.12 1699345 
3.45 1667827 6.12 1696777 
3.45 1660286 6.12 1693663 
3 3.45 1640578 
1640379.33 
6.12 1677269 
1670367.33 
3.45 1640578 6.124 1677269 
3.44 1640578 6.12 1674227 
3.45 1640578 6.125 1669467 
3.45 1640578 6.12 1665974 
3.44 1639386 6.123 1657998 
Average 1653904.67  1688130.33 
STD 27051.67  35526 
%RSD 1.63  2.01 
 
Acceptance Criteria: 
 The % RSD should be NMT 2 
INTERMEDIATE PRECISION  
 Intermediate precision (also called within-laboratory or within-device) is a 
measure of precision under a defined set of conditions: same measurement procedure, 
same measuring system, same location, and replicate measurements on the same or 
similar objects over an extended period of time. It may include changes to other 
conditions such as new calibrations, operators, or reagent lots. 
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Table No.7 System Intermediate Precision data 
Sample 
no. 
Ofloxacin Ornidazole 
RT Area response Avg. RT Area response Avg. 
1. 3.42 1653464 
1667690 
6.077 1685834 
1659193 
3.42 1688288                         6.077 1676686 
3.42 1646650 6.077 1669667 
3.42 1688288 6.077 1654992 
3.42 1643618 6.077 1640087 
3.42 1685834 6.077 1627891 
2. 3.42 1641046 
1646829 
6.077 1688288 
1677293 
3.42 1676686 6.077 1688288 
3.42 1635489 6.077 1676686 
3.42 1625190 6.077 1685834 
3.42 1654992 6.077 1669667 
3.42 1647572 6.077 1654992 
3.44 1639386 6.123 1657998 
Average 1657260  1668243 
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ASSAY SAMPLE  
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OFLOXACIN + ORNIDAZOLE 
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ASSAY SYSTEM SUITABILITY 
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7. RESULTS AND DISCUSSION 
The working condition for the HPLC established for Ofloxacin and Ornidazole 
and then was applied on pharmaceutical dosage forms (a combination of  Ofloxacin 
and Ornidazole tablet was used) . A simple reverse phase High Performance Liquid 
Chromatography has been developed and subsequently validated. 
 
The separation method was carried out by using a mobile phase consisting of 
Potassium dihydrogen phosphate buffer (0.05M): (Acetonitrile and Tetrahydrofuran 
35:1v/v) pH 3.5 ± 0.1 the ratio of 64:35 v/v.   
 
 The deduction was carried out by using UV detector at 300nm. The column 
was Agilent C 18 (250X4.6mm) 5µ. The flow rate was selected as 1.0ml/min.  
 
The retention time of Ofloxacin and Ornidazole was found to be 4.22 & 6.07. 
The number of theoretical plates of Ofloxacin and Ornidazole was found to be 
4518.60 & 7508.51 which indicates the efficient performance of the column. These 
parameters represent the specificity of the method. 
 
From the linearity studies, specified concentration levels were determined. It 
was observed that Ofloxacin and Ornidazole were linear in the range of 33.33% to 
166.66% for the target concentration by RP-HPLC. The linearity range of Ofloxacin 
and Ornidazole  33.33% to 166.66% µg/ml was found to obey linearity with a 
correlation coefficient (r2) of 1.012 & 1.110 respectively. 
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The validation of the proposed method was verified by system precision and 
method precision by RP-HPLC.  
 
The validation of the proposed method was verified by recovery studies. The 
percentage recovery range was found to be satisfied which represent in results. The 
ruggedness study was also performed. The robustness studies were performed. 
   
The validation of the proposed method was verified by system suitability. The 
% RSD of the system suitability for Ofloxacin and Ornidazole was found to be 0.447 
& 1.120. 
 
 The validation of the proposed method was verified by precision, recovery 
studies and solution stability. The percentage of precision, recovery studies and 
solution stability was found to be satisfied which represent in results. These are all 
comes under the specified limits and passes. 
 
 The analytical method validation was carried out by RP-HPLC as per ICH 
guidelines which are mentioned below as follows. 
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METHOD VALIDATION REPORT BY RP – HPLC 
 
S.No 
PARA-
METERS 
LIMIT OBSERVATIONS 
PASSES/ 
FAILS 
1 Specificity 
No Interferences at 
retention time of the 
peak. 
No Interference at 
retention time of the 
peak 
Passes 
 
2 Linearity 
Correlation co-
efficient (r2)         
NLT 0.999 
Ofloxacin -1.012 
            Ornidazole -
1.110  
Passes 
 
3. Precision %RSD NMT 2.0 
Ofloxacin -1.630 
 Ornidazole -0.982  
Passes 
4 Accuracy 
% Recovery range 
98-102% 
Within limits Passes 
5. Ruggedness 
RSD NMT  
2.0% 
Within limits Passes 
6. Robustness %RSD NMT 2.0 Within limits Passes 
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8. SUMMARY AND CONCLUSION 
    
A HPLC for Ofloxacin and Ornidazole was developed and validated in 
combined tablet dosage form as pre ICH Guide lines 
 
UV Detector and Agilent C 18 (250x4.6mm) 5µ column, injection of 20µl is 
injected and eluted with the mobile phase of Potassium dihydrogen phosphate buffer 
with pH3.5: (Acetonitrile & Tetra hydro furan35:1 v/v) in the ratio 64.9:35 which was 
pumped at a flow rate of 1.0ml at 300nm. The peak of Within limits was found well 
separated within 8min. The developed method was validated for various parameters 
as per ICH guidelines like system suitability, specificity, linearity, system precision, 
method precision, accuracy, ruggedness and robustness.  
 
The analytical method validation of Ofloxacin and Ornidazole by RP-HPLC 
was found to be satisfactory and could be used for the routine pharmaceutical analysis 
of Ofloxacin and Ornidazole. 
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